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ABSTRACT 
 
Protein-protein interactions (PPI’s) play important roles in biological systems.  In 
particular, intra-protein interactions help create and maintain correctly folded protein states and 
mutations that result in misfolded states may be associated with significant changes in PPI 
behavior.  Six unrelated protein systems with known structure files, each consisting of a wild-type 
and mutant strain, were studied using the computational algorithm OpenContact©.  OpenContact© 
is a simple tool that can be used to rapidly identify or map interactions “hot-spots” in a protein and 
was, consequently, used in this study as a starting point to examine the potential or possible role 
of PPI’s on the behavior of mutated, misfolded proteins.  Specific results include the observations 
of single chain protein systems exhibiting mutant strains with significantly stronger inter-atomic 
interactions as well as a surprising gain of secondary structure in the mutant state.  These 
observations stood in contrast to multi-chain systems (proteins with more than two constituent 
chains) that appeared to display stronger inter-atomic interactions for the wild-type strains.  Results 
also indicated a potential classification scheme for intra-protein interaction behavior in mutated 
states based on several criteria.  It is important to note, however, that observations on PPI behavior 
presented need to be verified across a greater number of systems than those studied here before 
any such trends can be concretely established.   
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1.0  INTRODUCTION 
 
 Proteins are important and extremely vital components of every organism on the planet.  
Their functions can range from structural support, to membrane transport, metabolism, cell cycle 
control, and many others.  It is therefore not surprising that serious health problems can manifest 
themselves should there be an aberrant expression of any protein such that its role and function 
are impaired, or altogether eliminated.  Although it is even possible that the novel form of the 
protein may incur beneficial effects to its host, these events are rare and the more prevalent 
scenario of aberrant protein expression is the manifestation of disease states.  It is therefore 
beneficial to consider the implications incumbent on mutations that result in misfolded proteins 
expressed differently from their natural or “wild-type” design.  Although mutations of any sort 
are not to be trivialized, the main class of mutations whose negative effects are to be considered 
in this work are inherited missense mutations that lead to congenital disease. 
 
 By contrast, mutations incurred throughout an organism’s lifetime typically affect cell 
growth and development which can lead to cancer.  These two holistic manifestations of disease 
between inherited and acquired mutations are ultimately different in how they affect the whole 
organism.  Although both can pose life-threatening scenarios, the treatments and considerations 
for each require different approaches despite the fact that mutations fundamentally lie at the heart 
of both scenarios.  As an example of the unique consequences of genetic damage that can lead to 
acquired mutations, one can turn to observations in the medical literature that document certain 
classes of tumors (i.e. ovarian, colorectal, renal, etc…) being associated with genetic damage to 
specific genes (Gao, Aksoy, Dogrusoz & et al., 2013).  For aberrant proteins resulting from 
inherited mutations, the approach to disease study and pharmaceutical development generally 
  
2 
 
rests on understanding how the protein’s structural differences between the wild-type and mutant 
strains results in said protein’s new bio-chemical and biophysical properties that effectively leads 
to disease (Jorgensen, 2004).  This is the approach that served as the foundation and perspective 
for the study that was undertaken for this thesis. 
 
2.0  BACKGROUND AND SIGNFICANCE 
 
 There exists a plethora of human disorders based on incorrectly folded proteins.  Whether 
one considers disorders as well-known as Cystic Fibrosis and Lou Gehrig’s disease or more 
obscure maladies such as Tay-Sach’s disease and Fatal Familial Insomnia, the underlying mode 
of biological sabotage remains the same: a protein or enzyme is misfolded due to a hereditary 
missense mutation or an acquired mutation that results in said protein or enzyme either losing its 
wild-type (and necessary) biological activity or gaining some activity detrimental to biological 
function (Reynaud, 2010).  As alluded to earlier, the importance of proteins in biological systems 
is immense.  In single celled organisms, they can be responsible for anything from membrane 
transport to digestion (save for autotrophic systems such as euglenas) to even motility (the 
archetype of which are the cilia of paramecia or the flagella of Helicobacter pylori) (Lefebvre, 
2001).  In viruses, proteins are responsible for reproduction regardless of viral classification 
(adenoviruses or retroviruses) and most notoriously of all, proteins are essential for host cell 
entry for all viral classes.  In plants, proteins play an important role in embryonic development in 
spermatophyte species (Soltis, Soltis, & Zanis, 2002).  Their importance is even more varied in 
complex multi-cellular organisms where proteins can play crucial roles in immunization, oxygen 
transport, structural support and even chemical defense for venomous and poisonous species.   
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Given the interplay, balance and dependence that many of these systems have with one 
another for multicellular organisms, one can quickly see that an interruption to any one 
component can have devastating domino effect-like consequences for the whole organism.  
Although the results of one system may not directly impact another by providing a bio-chemical 
product for subsequent use in the next biological process stream, impairing any biological 
function will place additional strain on any peripheral systems.  This strain can be inconvenient 
at best, or life-threatening at worst.  Thus, the importance for quantifying and thoroughly 
understanding these misfolding events is absolutely necessary to gain appreciation for the states 
of health and the treatment of disease. 
 
2.1  IN HUMANS: A CLOSER LOOK 
 
 In human systems, missense congenital mutations can lead to a variety of disorders that 
can affect a wide range of life support systems.  As an example, Cystic Fibrosis results from a 
mutation in the gene Cystic Fibrosis Transmembrane Conductance Regulator (CFTR gene) 
which ultimately leads to an improperly folded version of its respective protein that bears the 
same name: the CFTR protein (Andersen, 1938).  Under wild-type circumstances, this trans-
membrane cellular protein is responsible for the regulation of components in sweat and digestive 
fluids but more importantly, it is responsible for the movement of sodium and chloride ions 
across the membranes of epithelial cells such as the alveolar epithelia lining of the lungs as well 
as that of the pancreas and intestines (Andersen, 1938).  When a mutation occurs, this function is 
severely impaired if not eliminated (depending on the actual mutation) and leads to the thick 
mucus buildup in the lungs characteristic of cystic fibrosis.  Cascade events such as pulmonary 
infections, trouble breathing and poor oxygen delivery can then result complicating matters 
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further for the patient.  As of 2008, the median age of survival in the United States for this 
disease is 37 years (Andersen, 1938). 
 
Missense mutations that lead to diseases such as cystic fibrosis are not just limited to 
pulmonary epithelial cells, they can also strike and affect proteins critical to the central nervous 
system.  In Tay-Sach’s disease, a mutation on the HEXA gene (which codes for 
hexosaminidase’s, alpha, or “A” subunit) results in a defective version of the enzyme dimer 
complex, hexosaminidase (the hexosaminidase dimer has an alpha and a beta subunit) (Clarke, 
Mahuran, Sathe, & et al., 2004).  With the alpha or HEXA subunit improperly folded, the entire 
enzyme is rendered inoperative and incapable of executing its function: degrading ganglioside 
molecules from propagating ganglion cells of the brain (Clarke et al.).  With these molecules 
rapidly accumulating, they ultimately take on toxic properties that lead to the premature death of 
the brain’s nerve cells (Clarke et al.).  The progressive deterioration of these cells results in a 
decline of mental and physical abilities that can start as early as six months of age in patients 
suffering from the infantile form the disease (Clarke et al.).  Examples of functions that are 
eventually lost are swallowing and breathing (Clarke et al.).  As there is no cure for Tay-Sach’s 
disease, the ultimate prognosis is death which is around four years of age for sufferers of the 
infantile version but can be variably longer for sufferers of the late onset forms of this disorder 
(Clarke et al.). 
 
Although the negative effects of misfolding events due to mutations has been strongly 
emphasized and illustrated up to this point, it is important to keep in mind that not all mutations 
result in entirely negative consequences for the carrier.  A very interesting example that 
illustrates this is the mutation known as CCR5 delta 32.  This mutation results from a deletion of 
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32 base pairs on a gene known as the CCR5 gene that is normally responsible for expressing the 
CCR5 protein on the surface of white blood cells such as T cells, macrophages and dendritic 
cells (Buseyne, Janvier & Teglas, 1998).  Under normal circumstances, this cellular surface 
protein is responsible for serving as a receptor cite for chemokines during immune and immune-
related inflammatory responses.  When the deletion mutation manifests itself however, the CCR5 
protein either fails to be expressed, or is expressed in considerably lower quantities (Buseyne et 
al., 1998).  This has considerable ramifications for viruses that may make use of the CCR5 
receptor protein to gain entry into their host cells.  HIV is the quintessential virus that wreaks 
havoc through the CCR5 cellular receptor and those individuals who manifest the mutation either 
have total immunity to HIV or are able to maintain the viral population at considerably low 
levels (these specific individuals are known as long-term-nonprogressors or elite controllers) 
(Buseyne et al., 1998).  Due to the inherited genetic nature of this mutation, replicating these 
altered white blood cells are of active interest in the gene therapy community.  The importance of 
this case serves to establish and emphasize the point that although genetic mutations leading to 
misfolded or entirely absent proteins can lead to disease, they can confer a genetic advantage if 
the mutation occurs at the right place and time. 
 
3.0  RESEARCH OBJECTIVES 
 
For the content of this thesis, a total of six misfolded protein cases, or systems, were 
selected, in part, based on the availability of molecular structure files for both wild and mutant 
forms of the same protein.  Systems containing mutations affecting cysteine residues which 
would result in the disruption of intra-protein disulfide bridges and, consequently, 
dramatic/obvious structural changes were purposefully omitted from this study.  Each one of the 
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six cases were identified from the literature and separately analyzed.  Each system analyzed was 
therefore comprised of two protein structure files: a wild type protein structure file and a mutant 
version of the same protein.  As in the foregoing general examples of diseases stemming from 
protein misfolding, the six systems analyzed for this project also resulted in disease states, but 
unlike the examples mentioned above, many of the actual systems’ respective maladies 
considered for this project are not as well documented or studied due to the fact that they are not 
as prevalent or the necessary structure files have only been recently determined. 
 
 The overall goal and objective of the research reported here was to identify and quantify 
the differences in the intra-protein interactions between a wild type protein and a mutant version 
of that same protein.  Consequently, the scope of this project was solely at the intra-protein level.  
The strategy for determining these differences was via a computational approach based on 
mapping of the inter-atomic potential field using AMBER 03 force field model.  Initially, it was 
thought that the mutant version of the protein would generally exhibit weaker intra-molecular 
interactions and a loss of structure compared to the wild type version of the protein.  
Interestingly, although some systems did exhibit this trend, this was not always the case.  Two 
pieces of software were particularly useful and instrumental in reconciling this information: 
OpenContact© and DS-Viewer Pro®.  OpenContact© provided the computational data and 
mathematical models surrounding the inter-atomic forces, interactions and distances within each 
protein that was analyzed.  DS Viewer Pro in turn provided qualitative structural visualization 
images for each protein.  In all, data for each system thus consisted of numerical data for the 
binding parameters analyzed as well as visual molecular images detailing the differences in 
tertiary and quarternary structure between each case’s wild-type and mutant strains. 
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3.1 MOLECULAR MECHANICS: FOUNDING PRINCIPLES 
 
 The computational criterion for quantitatively determining the interatomic attractions and 
forces is founded on the discipline of molecular mechanics.  Molecular mechanics is an 
application of classical mechanics (or Newtonian mechanics, the most common branch of 
physics) to model the movement of the individual atomic constituents in molecular systems 
(Kuhn, Kollman, & et al., 2000).  This discipline is used to study a wide range of chemical 
species behavior ranging from small organic molecules containing only a few atoms, to large 
biological macromolecules such as proteins and DNA which may contain anywhere from several 
thousand to several million atoms.  As alluded to earlier, the calculations that provided the 
quantitative data for this project were ultimately executed by OpenContact©, a computer 
algorithm, but the fundaments of the underlying code are all based upon what follows in this 
section and needless to say, the calculations are performed by the algorithm for as many atoms 
that are present in the system being analyzed. 
 
 In its most basic manifestation, molecular mechanics models systems via an “all-atom” 
approach:  each individual atom in the molecule is treated as a single particle (Kuhn et al., 2000).  
Each particle in turn, is then assigned a radius (most typically the van der Waals radius), along 
with a variety of different parameters that account for polarizability, constant net charge and 
bond angles (more on these parameters later) (Kuhn et al., 2000).  The bonded interactions are 
modeled as stiff mechanical springs with an equilibrium distance equal to the experimental or 
calculated bond length (Kuhn et al., 2000).  As will be explored in greater detail shortly, the 
particular force field parameters assigned to each atom follow from large scale quantum 
mechanical calculations.  Note that there are additional variations of this paradigm in use such as 
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the “united-atom” model, which treats each terminal methyl group or intermediate methylene 
unit as a single particle, and the so-called “bead” model which assigns two to four particles to an 
individual amino acid in a protein system (Kuhn et al., 2000).  It is the “all-atom” model 
however that finds use in this project via the OpenContact© software and, thus, the data that 
follows in the coming sections is entirely from an atomic perspective. 
 
 Now that the modeling technique has conceptually been defined, it is appropriate at this 
point to specifically detail the mathematical treatment of the “all-atom” model or potential 
function.  From a mathematical and physical perspective, the molecular mechanics calculations 
are based simply a summation of a variety of different potentials inherent in a molecular system.  
The two most fundamental categories of these potentials are the collective potentials governing 
covalent bonding between atoms and the collective potentials governing non-covalent bonding 
(i.e. electrostatic attractions).  These two master families (covalent and non-covalent) are then 
added together to give the total potential energy of the molecule under study.  Therefore 
mathematically the functional form of the potential function is (Kollman, Massova, Reyes, & et 
al., 2000), 
 
(1) 𝐸𝑇𝑂𝑇 = 𝐸𝐶𝑂𝑉𝐴𝐿𝐸𝑁𝑇 + 𝐸𝑁𝑂𝑁−𝐶𝑂𝑉𝐴𝐿𝐸𝑁𝑇 
 
where the covalent term is, 
 
(2) 𝐸𝐶𝑂𝑉𝐴𝐿𝐸𝑁𝑇 = 𝐸𝐵𝑂𝑁𝐷 + 𝐸𝐴𝑁𝐺𝐿𝐸 + 𝐸𝐷𝐼𝐻𝐸𝐷𝑅𝐴𝐿 
 
and the non-covalent term is, 
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(3) 𝐸𝑁𝑂𝑁−𝐶𝑂𝑉𝐴𝐿𝐸𝑁𝑇 = 𝐸𝐸𝐿𝐸𝐶𝑇𝑅𝑂𝑆𝑇𝐴𝑇𝐼𝐶 + 𝐸𝑉𝐴𝑁 𝐷𝐸𝑅 𝑊𝐴𝐴𝐿𝑆 
 
Eqs. (2) and (3) contain some of the potentials briefly mentioned in the foregoing paragraphs and 
we now see where and how exactly these potentials are prescribed in the grand scheme of 
molecular mechanics calculations. 
 
 Each term in Eqs. (2) and (3), in turn, are defined according to specific potential models.  
Starting with Eq. (2) (modeling covalent bonding), the bond and angle terms (EBOND and EANGLE) 
are typically modeled as harmonic potentials centered about equilibrium bond length values.  
This approach makes use of the classical setup commonly seen when analyzing the equations of 
motion for periodically occurring phenomena such as a swinging pendulum or (as is most 
appropriate in the present case of a chemical bond) a spring rapidly expanding and contracting.  
Such a harmonic potential may therefore be of the form, 
 
(4) 𝑥(𝑡) = 𝐴𝑐𝑜𝑠(𝜔𝑡 + 𝜙) 
 
where, 
 
𝜔 = √
𝑘
𝑚
=
2𝜋
𝑇
 
 
which would represent the angular frequency of bond vibration.  The dihedral term in Equation 2 
(EDIHEDRAL) is modeled with the appropriate potentials, but they tend not to be harmonic 
oscillators and their various functional forms tend to vary with the specific implementation of the 
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potential function.  Improper dihedral mathematical models may be included to enforce the 
planarity of aromatic rings and other conjugated systems. 
 
 For the non-covalent interactions considered in Eq. (3), the electrostatic term 
(EELECTROSTATIC) takes into account any inherent charges possessed by the constituent atoms of the 
protein due to electron deficiencies or excesses as well as dipole, quadrapole, or higher moments 
due to shifting electron positions.  It is modeled with Coulomb’s law for two point charges 
(Peters, 2007), 
 
(5) 𝑢(𝑟) =
𝑞1𝑞2
𝑟
 
 
where q1 and q2 are the charges of each point and are given in electrostatic units (1 esu ≡ 1 
dyne1/2▪cm).  The van der Waals term (EVAN DER WAALS) in Equation 3 further considers BOTH the 
short range (Born) repulsive forces and the longer-range (van der Waals) attractive forces present 
at the intermolecular level (Peters, 2007).  These forces, although similar in concept to the 
electrostatic forces previously mentioned, primarily differ in the sense that van der Waals forces 
are associated with oscillating, time-dependent electric fields created by the wave, or 
probabilistic behavior, of electrons in atoms (by themselves, van der Waals forces are 
mathematically modeled as r-7 where r is the separation distance between the two species) 
(Peters, 2007).  This is in distinction to the more fixed nature of positive or negative charge that 
is modeled by Coulomb’s law.  Although the term in Eq. 3 primarily bears the name van der 
Waals, it is important to note that the specific potential function actually used incorporates both 
Born and van der Waals repulsions and attractions respectively.  On the atomic scale, the precise 
nature of Born repulsive forces manifest themselves when two atoms (or molecules) approach 
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each other at distances slightly larger than σ where σ is the atomic or molecular diameter.  At 
these very small separation distances, the electron shells of the two molecular (or atomic) species 
partially penetrate each other (Peters, 2007).  The nuclei of the constituent atoms (which are 
positively charged) are now no longer shielded by their respective electron shells and so they 
now repel one another.  It is important to note that the scenario of Born repulsion, despite the 
physical similarities with covalent bonding, differs from covalent bonding in that no electrons 
are shared by the two species in question in the Born set up.  Both Born and van der Waals 
interactions are thus modeled in Eq.(3)’s EVAN DER WAALS  term using the Lennard-Jones Potential 
(Stobener, Klein, Reiser, Horsch, Kufer, & Hasse, 2014), 
 
(6) 𝑢(𝑟) = 4𝜀 [− (
𝜎
𝑟
)
6
+ (
𝜎
𝑟
)
12
] 
 
where 𝜀 and 𝜎 are constants related to the energy minimum and distance at minimum, 
respectively. 
 
3.2 FORCE FIELDS: MOLECULAR MECHANICS APPLIED 
 
 As stated in the previous section, the ultimate manifestation of the mathematical engine 
that drives OpenContact©’s calculations is the atomic force field and associated parameters.  It is 
crucial to make the distinction however of what is meant by the term “force field” in chemistry 
and computational biology as opposed to its more common usage in physics.  In chemistry, a 
force field refers to a system of potential energy functions like the kind that have been discussed 
in the Equations 2 and 3.  This stands in contrast to the definition of a force field in physics as 
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being the gradient of a scalar potential (Peters, 2007).  Another important concept to be 
cognizant of is that despite the fact that the equations in conjunction with their parameters are 
called “force fields”, the quantities that the equations actually provide are potentials, not forces.  
Strictly speaking, the force is defined mathematically as the negative of the first derivative of the 
potential function with respect to distance.  In addition to providing information on each element 
present in the molecule, the parameters also include specific constants for the properties of these 
atoms as they appear in different functional groups such as carbonyl and hydroxyl oxygens 
(Krall, Brunn, Kankanala, & Peters, 2014).   
 
The parameter sets used in proper force field analysis include data for van der Waals 
radii, partial charges, atomic masses, equilibrium values for bond lengths and angles, dihedral 
angles for bonded atoms and the effective “spring constants” for each bond potential (recall that 
in molecular mechanics, bonds are well approximated by the physics of an actual expanding and 
contracting spring) (Krall et al., 2014).  An important point of emphasis is that despite the fact 
that these values and constants are ultimately employed on a holistic perspective of the entire 
protein under study, the values themselves are derived primarily from quantum mechanical 
models on small and simple organic molecules (Cornell et al., 1995).  As will be seen in the next 
section, there are many force field models currently available for intra and inter molecular 
interaction studies, and each model has its own set of parameters.  These parameters are defined 
by force field developers to be self-consistent within the parameters’ respective force field model 
and should therefore never be used in conjunction with the potential equations from another 
force field model, no matter how similar parts of the models may be. 
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3.3 AMBER 03: OPENCONTACT© DEFINED 
 
 The specific force field model used by OpenContact© is the AMBER 03 force 
field.  AMBER is an acronym standing for Assisted Model Building with Energy Refinement.  
AMBER 03 follows the skeletons of Eqs. (2) and (3) and it has its own set of parameters for van 
der Waals radii, bond lengths, etc….  There do exist other members of the AMBER family of 
force fields that are popularly used but as mentioned earlier, each has its own exclusive 
parameter sets that will only work with the force field model to which it belongs and it is this 
proprietary attribute that defines the differences between individual members of the AMBER 
family (Cornell et al., 1995). 
 
Given that the parameter sets are the only attributes that differ between AMBER family 
members, it should come as no surprise then that the foundational molecular mechanics potential 
function for the AMBER family of force fields remains the same for each currently available 
AMBER family member.  The actual functional form of the AMBER equation is (Cornell et al., 
1995), 
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For the right hand side of this equation, the first term, which sums over bonds, models the 
potential energy between covalently bonded atoms (Cornell et al., 1995).  The classical spring 
model is a good approximation for atoms participating in bonds, so long as the bound atom 
distance (l) remains relatively close to the equilibrium bond length (l0).  This model begins to 
give poorer results, however, as the distance of binding is increased (Cornell et al., 1995).  The 
second term, which sums over the angles of electron orbitals (θ), models the potential energy of 
electron orbitals involved in covalent bonding (Cornell et al., 1995).  The third term, which sums 
over torsion angles (ω), models bond rotation as influenced by bond order (i.e. double bonds vs. 
single bonds) and neighboring charge clouds (i.e. vicinal bonds on the same atom and electron 
lone pairs) (Cornell et al., 1995).  It is possible for any given individual bond to have more than 
one of these terms and in such cases, the total torsional energy potential would be expressed as a 
Fourier series (Cornell et al., 1995).  The fourth and last term (the double summation over i and 
j) models the interactions arising from non-covalent force sources where rij is the distance 
between the two interacting atoms in the system (Peters, 2007).  Recall that these forces were 
identified as being modeled by the Lennard-Jones potential for those non-covalent interactions 
(7) 
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arising from time-dependent electron oscillation phenomena and Coulomb’s law for charged 
atomic species. 
 
4.0 MATERIALS AND METHODS: PRIMARY CONSIDERATIONS 
 
 At its foundation, this research project was purely computational and entailed feeding 
raw protein structure data files into a suite of software applications to provide the desired output 
data.  This data then had to be compared (wild-type against mutant) to identify any differences 
between wild-type and mutant strains.  Ultimately, this required understanding the systems that 
were going to be under study and establishing test subjects (the input data files) that had minimal 
variability from one to the other within its respective system (a system being defined as a wild-
type strain in conjunction with its mutant counterpart).  Having an availability of both wild-type 
and mutant data files in the first place was another criterion that had to be considered and 
satisfied before a system could be approved for study.   
 
Minimizing variability was a very important consideration in identifying which protein 
systems would be analyzed.  Each system had to, first and foremost, have its wild-type and 
mutant strains come from the same organism.  There were a plethora of promising systems that 
either came from cattle, mice or even invertebrates such as insects and worms, but since the 
focus of this research project was disease in humans, the ultimate candidates chosen had to come 
from Homo sapiens, the species of man.  The next criterion considered in minimizing variability 
within each system was data file similarity.  As shall be discussed shortly in greater detail, the 
input data files essentially map the positions of each constituent atom of their respective proteins 
in space.  In many cases, there were multiple input structure data files for the same protein, from 
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the same species, but which covered/mapped entirely different regions of said protein.  Naturally, 
a system comprised of dissimilar locations for the wild-type and mutant strains would be of no 
use to a systematic and rationalized study and so input structure data files had to be found that 
had as much overlap as possible.  An approved system would thus finally consist of both a wild-
type and mutant strain (thus satisfying availability), and a wild-type and mutant set of structure 
data files that had as much protein region overlap as possible (thus satisfying variability 
minimization).  Finally, it was decided that any system considered should not contain a cysteine 
amino acid mutation, since these mutations can drastically alter the three-dimensional structure 
of the protein, and the focus of this study was more on the subtle changes that could be incurred 
from amino acid replacements that did not necessarily change protein structure.  Although 
residue mutations are the featured aberrancy in this study, it is important to keep in mind that 
other factors associated with the environment of the system (i.e. pH, presence of solutes, 
temperature etc…) can also have a profound effect on protein behavior.  Thus this research 
project only looked at just one aspect of how mutation states can affect protein-protein 
interactions. 
 
4.1 MATERIALS AND METHODS: PDB FILE ANATOMY 
 
The input data files came from the Protein Databank or pdb website (www.rcsb.org) and 
are consequently called “pdb files.”  They are logged and registered in the databank according to 
an accession number unique to each protein entry.  These accession numbers are usually a 
combination of alpha-numeric characters and they constitute the file name upon downloading.  
The pdb files are inherently text files that can be viewed with any simple text editor.  Notepad++ 
was specifically used to view and study the pdb files due to this piece of software’s designed 
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purpose of viewing machine instructions in interpreted code (i.e. high-level programming 
languages).  Although fundamentally pdb files bear the “.txt” file extension, they have an 
additional appellative of “.pdb” following the normative “.txt” extension.  It is the “.pdb” sub-
extension that allowed these input data files to be read by the various computer programs used 
which will be discussed in more detail in the coming sections.  Here is a sample pdb file name as 
would be downloaded from the Protein Databank: 4BXO.pdb. 
 
 What type of information specifically is encoded in these pdb files?  The answer to this 
question is a set of coordinates that detail where in space (a Cartesian-like x-y-z volume) each 
and every constituent atom of the protein is located.  This information is gathered from X-ray 
crystallography studies, NMR assays or neutron diffraction studies.  None of the test cases 
reported here had their structures elucidated from the neutron diffraction assay however.  From 
the visualization software’s (DS Viewer Pro’s) perspective, this information is plotted and each 
successive atom or point is connected to yield the overall tertiary structure of the protein.  For 
multi-chain proteins (which have each separate chain encoded in the same pdb file), each 
individual chain’s atoms are also plotted and connected in the same space and the resulting 
quaternary structure is then presented to the user.  The section of the pdb file that encodes atom 
positions obeys the skeleton as shown in Fig. A1 (see appendix).  Below is the definition for each 
column entry: 
 
 Column1: field for the actual species to be plotted, which for this example is an atom. 
 Column 2: field for the sequential number of the corresponding atom (the value of this 
field will naturally increase by one as one moves down Column 2). 
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 Column 3: field for the specific atom name with respect to the amino acid residue to 
which the atom belongs (i.e. the alpha carbon, amino nitrogen, carbonyl oxygen, etc…). 
 Column 4: field for the standard three-letter amino acid code for the residue. 
 Column 5: field for the protein chain that particular residue’s atom belongs to. 
 Columns 7, 8 & 9: fields for the x-y-z coordinates respectively of each atom. 
 Column 10: field for the occupancy value of the atom. 
 Column 11: field for the thermal factor of the atom. 
 Column 12: field for the explicit chemical element of the atom (i.e. carbon, nitrogen 
etc…). 
 
This example was taken from the transthyretin protein (accession number: 3D7P), one of the test 
cases.  Following the plotting of the above data, DS Viewer Pro then allows rotation of the image 
to see the three dimensional structure in depth and from different angles.  There are a host of 
other features likewise available in DS Viewer Pro that allow for selective hi-lighting of amino 
acid residues, labeling the distinct chains (if there are more than one) and zooming in to regions 
of interest on the protein, just to name a few.  It is important to keep in mind however that 
despite the fact that the pdb file encodes raw atom positions, the output labelling is primarily 
from the perspective of the amino acid residue.   
 
 In addition to atom positions, the typical pdb file will also include information on the 
type of experiment that yielded the protein’s structural results (i.e. X-ray diffraction, NMR, 
neutron scattering), the resolution of the imaging, the position of mutations in the primary 
structure of each protein chain (if the pdb file is of a mutant strain), the name of the protein, any 
missing atoms or residues, and the names of the authors who elucidated the structure.  
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Depending on the depth of study from the researchers who compiled the pdb file, there may even 
be a section detailing additional suggested pdb accession numbers for related protein structures.  
Figures A1 and A2 show snapshots of the two important sections of a typical pdb file (taken 
again from transthyretin-3D7P), 
 
4.2 MATERIALS AND METHODS: OVERALL EQUIPMENT 
 
 Due to the computational nature of this research project, the principal pieces of 
equipment consisted of two main classes: computer hardware and software.  Hardware-wise, a 
Dell® Inspiron 15 laptop computer with an Intel® Inside™ CORE™ i3 processor with 4 
gigabytes of RAM was used.  Data was saved on said machine as well as on various disk drives 
for backup in case of primary storage failure.  Software-wise, OpenContact© was used to 
process raw input data (the pdb structure files from the Protein Databank) and consequently 
provided quantitative output calculation results for criteria such as inter-atomic distances and 
Lennard-Jones Potentials which was then processed and organized using Micrsoft Excel 
spreadsheeting.  OpenContact© also provided qualitative contact mapping plots for the same 
inter-atomic criteria mentioned above as well as molecular visualization files of the output data 
for qualitative analysis as well.  Consequently, the other indispensable piece of software used 
was DS Viewer Pro®, a molecular visualization program that would read the same input files 
that were fed to OpenContact©, but instead provided output in the form of a 3 dimensional 
image of the protein encoded by the input data.  As with many available molecular visualization 
software, DS Viewer Pro® permits for the rotation of the three dimensional images so as to allow 
viewing the molecules from different angles. 
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4.3 MATERIALS AND METHODS: DS VIEWER PRO®-THE FIRST STEP 
 
 Once a protein system was selected, the first step in analysis was looking at the entire 
structure of both wild-type and mutant strains.  Such a qualitative approach served to primarily 
gain an appreciation and knowledge of the location of the general residues potentially involved 
in intra-protein binding.  The software that was used to provide these molecular visualizations 
was DS Viewer Pro by Dassault Systems BioVia.  Despite the fact that there were a number of 
other molecular visualization programs available for potential use, DS Viewer Pro was ultimately 
selected due to the publication quality of its output data files.  The actual artistic representation 
style of the protein structure deployed by DS Viewer Pro was in the hands of the user.  The most 
common method seen thus far by the author in text-books and scientific articles is the flat ribbon 
representation.  Below is a sample of this representation of molecular structure, again, for 
transthyretin, accession number 3D7P, 
 
 
Fig. 1: Flat ribbon representation of transthyretin (wild-type). 
 
As alluded to earlier, DS Viewer Pro Due provides many features to the user in displaying 
protein structure from pdb files.  One such feature that proved to be most curious but useful in 
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studying the detailed position of residues and their constituent atoms was the option of 
overlaying a wire-frame representation of each and every atom present in the pdb file over the 
general flat ribbon structure.  The same transthyretin structure with its atoms overlaid the ribbon 
representation is shown in Figure A3.  Other representation schema available included wire, 
stick, line ribbon and schematic, to name a few.  The same transthyretin protein is shown in Figs. 
A4-A7 in these different representations.  It should be noted however that in some specific 
instances to be seen later, the schematic representation (Fig. A7) proved to be more appropriate.   
 
 One of the more powerful and informative features of DS Viewer Pro was the ability to 
see and selectively hi-light residues in a protein structure.  The following image showcases this 
ability for the same wild-type transthyretin model with the specific amino acid that was to be 
mutated in the mutant pdb file, here hi-lighted yellow, 
 
 
Fig. 2: Transthyretin with valine at the 30th position hi-lighted 
 
Next is the same image, but with the residue names showing.  Again, the same amino acid is hi-
lighted in yellow. 
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Fig. 3: Transthyretin with all residues displayed; valine at 30th position hi-lighted yellow 
 
It is important to note however that select residues such as valine at the 30th position cannot be 
solely displayed all the while ignoring (i.e. not displaying) the other residues in the protein.  If 
such images are desired, a manual labeling via the use of superimposed text boxes over the bare 
protein structure would have to be employed. 
 
4.4 MATERIALS AND METHODS: OPENCONTACT©- THE NEXT STEP 
 
 Following the preliminary structure viewing of the overall protein system, the next step 
was to execute OpenContact© on both the wild-type and mutant strains for the given system 
under study.  OpenContact© is a simple, yet powerful static contact mapping algorithm that has 
been developed as a first step at identifying binding “hot-spots” in protein-protein interactions 
from interaction partner structure files (Krall et al., 2014).  The algorithm is fast and provides 
results on a Windows© based laptop or PC within approximately two minutes even for large 
protein systems.  It has been demonstrated that OpenContact© is capable of identifying key or 
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critical inter-atomic hot-spots in PPI’s previously obtained via more sophisticated methods such 
as MD or docking methods (Krall et al., 2014).  Again, such results furnished by this algorithm 
were provided very quickly within a two minute time window and it additionally had the benefit 
of not requiring the user to have any sophisticated knowledge associated with carrying out large 
scale MD or docking methods.  Thus, a large number of systems can be quickly mapped as an 
initial step to potentially ascertain the roles of PPI’s in protein behavior.  What now follows is a 
general overview of the input protocol and considerations for inputting the pdb data file into 
OpenContact©.  As has been discussed thus far, OpenContact© calculates inter-atomic distances, 
and force potentials by reading in the pdb files containing atomic position data.  The exact nature 
by which this is done is by first specifying the two chains of the protein that one wishes to study 
(only two chains can be analyzed at any given algorithm execution however).  Below is a 
snapshot of the graphical user interface (GUI) of OpenContact© by which this first step is taken, 
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Fig. 3: OpenContact© GUI 
 
Several details worth noting from this image are the two populated browse input fields located in 
the section marked “Protein Input.”  It is in this field that the user would specify (most 
conveniently by using the browse buttons with folder icons) the directory pathway of the input 
pdb files.  Again, there are two pathway fields to allow the study of the interactions of two chains 
(Krall et al., 2014).  Since the backbone of these computational calculations is the actual 
structure encoded by the pdb file, the two pathways will naturally direct to the exact same file.  
This will not always be the case however, especially with single chain protein systems as will be 
seen shortly.  The next item to consider in Fig. 3, still in the “Protein Input” section, is the “Chain 
ID” input text box located immediately underneath each directory pathway.  As this field’s name 
  
25 
 
suggests, the appropriate input to this field is the specific chain one wishes to include in the 
computation study (Krall et al., 2014).  It is absolutely important that the chains specified are 
actually logged in the pdb file however, as the program will be unable to proceed if it is unable to 
find what is provided.  Once directory pathways and chain ID’s have been specified, the “Add” 
button must then be clicked to formally feed these results into OpenContact©.  Following pdb 
file and chain specifications, the next two items of consideration are now in the section titled 
“Options.”  The pathway field marked “Output Destination” would point to a directory location 
where the user would like to store the output files generated by OpenContact©.  The text box 
marked “Filename Convention” would direct OpenContact© with the paradigm for naming the 
output files (Krall et al., 2014).  As can be seen, file-naming by date of creation, protein names 
and batch id are some options left to the user to choose from.  Finally, the radio button marked 
“Create new folder for each mapping” does as its name suggests: if the same overall destination 
folder is maintained for separate runs, each run will be stored in a newly created folder 
automatically generated by OpenContact© (Krall et al., 2014).  Once each of the aforementioned 
fields have been populated and the “Add” button depressed, the last and final step of the data 
input protocol is to depress the bottom-most button marked “Run.”  A green bar will then 
qualitatively indicate the stage of the program’s data processing (i.e. the green bar will grow as 
the process approaches completion) and once the procedure is complete, the output files will be 
stored in the directory specified. 
 
 The precise nature of the output data files is essentially divided along two criteria: fine 
parsing and coarse parsing, of the calculated potentials and distances (Krall et al., 2014).  For the 
coarse parsing criterion, atom-atom separation distances greater than 10.5 angstroms are 
excluded from the final data file (Krall et al., 2014).  In the fine parsing of the interactions, an 
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additional restriction on the atom-atom interaction potentials are specified.  For all the results in 
the coming sections, the upper limits to restrict Coulombic and Lennard-Jones interactions are 
(respectively) (Krall et al., 2014), 
 
(8) 𝑈𝐶𝑜𝑢𝑙
∗ ≤ −0.3 
 
or, 
 
(9) 𝑈𝐿𝐽
∗ ≤ −0.1 
 
where, 
 
(10) 𝑈∗ =
𝑈
𝑘𝑇
 
 
for both interaction criteria.  In Equation 10, k is Boltzmann’s constant and T is temperature 
taken as 310.15 K for all results that follow (Krall et al., 2014).  Consequently, the values 
reported by OpenContact are dimensionless where potentials have been scaled by kT and 
distance has been scaled by 1 nano-meter.  These potential energy cut-offs ensure that only the 
strongest attractive interaction potentials for any given type are included in the fine parsing 
results which are provided to the user in a highly manageable and user-friendly format in both 
“.pdb” and “.txt” file types (the “.txt” file is purely a text file that allows its data content to be 
properly imported into Microsoft Excel for spreadsheeting) (Krall et al., 2014).  The data can 
now be analyzed, plotted and generally manipulated according to the user’s needs as shall be 
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seen in the coming cases.  At its most basic, the fine parsing data thus provides which atom-atom 
interaction pairs exhibit the strongest interactions, whereas the coarse parsing data provides 
which atom-atom interaction pairs contribute most to the structure involved in the inter-chain 
bound region (Krall et al., 2014).  For the studies that follow in this research project, the coarse 
parsing data provided the greatest insight into the structural changes exhibited by mutant strains 
compared to their wild-type counterparts.   
 
 Following the above data input protocol, the user is now able to do one of two things: 
view and manipulate the output data files, or create a contact mapping plot of the two chains 
based on Coulombic, Lennard-Jones or distance criteria.  This plot inherently uses the output 
data from the fine parsing files already generated but it presents that data in a pictorial format 
that provides a very nice overview of the atom-atom interactions between the two chains 
specified.  Below is a snapshot of such a plot, again, for wild-type transthyretin, accession 
number 3D7P, 
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Fig. 4: Contact map plot for distances between atoms in chains  
A and B for transthyretin. 
 
As can be seen in Fig. 4, the corresponding x and y axes display specific atoms involved in the 
interactions between chains A and B for transthyretin.  The y axis (marked “Protein A”) presents 
the participant atoms from the A chain in ascending order (from the bottom of the axis to the top 
of the axis) and the x axis (marked “Protein B”) presents the corresponding atomic partners from 
the B chain that interact with the A chain atoms.  The atoms in the x axis are not in any particular 
order however.  It is important to also note that despite the fact that a certain number of atoms 
may be explicitly presented in the above plot, the actual fine parsing analysis may detect 
hundreds more.  Again, these plots are more qualitative in nature, but they can provide a very 
good overall picture of how the system’s wild-type or mutant strains interactions behave.  The 
informative nature of the plot ultimately comes from the bright colors in the actual plot area: 
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brighter colors at certain ordinate and abscissa intersections indicate stronger interactions, or, as 
is the case for Fig. 4, closer separation distances.  The color-coded legend to the right of the plot 
in the figure provides a neighborhood for the corresponding values.  Although powerful, for the 
present application, these contact plots were not used, as structure image files were the central 
starting point for analysis of the input files and results. 
 
 As briefly mentioned in the preceding paragraphs, OpenContact’s cut-off limits were 
determined to be efficient for the research project undertaken by Peters et al. which was finding 
regions of certain proteins involved in disease that were amenable to synthetic peptide (bio-
mimetic peptide) targeting for therapeutic use.  A total of six unrelated protein systems were 
analyzed in the Krall et al. study and included gp41 (a glycoprotein belonging to HIV that is 
necessary for host cell entry), the EpherinB4-EpherinB2 system (a cell-cell signaling 
angiogenesis stimulation mechanism), Myc-Max (a transcription factor hetero-dimer complex 
involved in cell proliferation), and EGFR-EGF (a cell growth factor system).  According to the 
results of the study, the OpenContact© algorithm “efficiently predicted proposed peptide 
biomimetics, or close variations thereof” when compared against peptide mimetics that had been 
proposed and/or developed for these systems to some degree of success by purely experimental 
methods (Krall et al., 2014). 
 
 
4.5 MATERIALS AND METHODS: OUTPUT FILE ANATOMY 
 
Since the primary focus of this study was interaction changes from the wild-type to the 
mutant version of the protein, the discussion that follows comes from the results of the fine 
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parsing output data.  Coarse parsing data obeys the same format however.  These results 
generated by OpenContact© were consequently interpreted in the following manner.  First the 
entire protein system was analyzed holistically by summing the two potential criteria (Coulombic 
and Lennard-Jones) for both the wild-type and mutant strains.  This permitted seeing how the 
totality of interactions changed on a big picture scale.  The interatomic distances by contrast 
were averaged to get a sense of how average distances changed.  Then, common interaction 
partners amongst the two strains were identified and only the common interaction potentials and 
distances were summed and averaged respectively as described for the holistic scenario.  From 
the fine parsing data (imported into Microsoft Excel), common interaction partners were hi-
lighted in green to differentiate them from interactions unique to each strain.  Two corresponding 
common entries for transthyretin’s fine parsing analysis are shown in Figs. 5 and 6. 
 
 
 
 
Fig. 5: Fine parsing analysis data for transthyretin.  The wild type results are in the left-hand 
table, mutant results are at the right.  Two sample common interaction entries are bordered in red. 
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Fig. 6: Fine parsing data hi-lighting actual data content.  The columns headed by “RRS” (blue), 
“UCOUL” (magenta) and “UL” (orange) contain the data for distance, Coulombic potentials and 
Lennard-Jones potentials respectively. 
 
What is ultimately meant by common interaction partners refers solely to the entries 
headed by “RES A,” “RES NUM,” “ATOM A,” and “RES B,” “RES NUM,” “ATOM B” in the 
column titles in Figs. 5 and 6.  Should the individual entries in these columns within one table 
identically coincide with entries in the same columns in the other table, then those elements 
within the two tables were considered common interaction pairs.  As mentioned earlier, some 
structural elucidation assays may result in certain atoms or residues not being detected and thus 
not reconciled in the pdb structure file.  This would result in those residues or atoms being 
omitted from the orderly enumeration dictated by the “ATM NUM” column.  It is for this reason 
that this column is not used in determining common interaction partners: individual atom 
numbering may change from experiment to experiment, but residue numbering never does. 
 
4.6 MATERIALS AND METHODS: DATA RECONCILIATION 
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 Since the ultimate goal of this research project was to compare the interactions between 
wild-type and mutant strains of the same protein, the overall approach was to sum the three 
interaction criteria together (or average them for the distance criterion) and compare the results.  
In turn, these interaction totals were carried out over three analysis considerations: an overall 
comparison, a common atom comparison and a non-common comparison.  The overall 
comparison was simply a total of each of the interaction criteria (Lennard-Jones potential, 
Coulombic potential and distance) and the total of each criterion was compared between the 
wild-type and mutant strains.  The common atom comparison consisted of identifying the atom-
atom interactions that were found in both the wild-type and mutant strains (green text in Figures 
5 and 6), summing these values for each strain and then comparing the sums.  The non-common 
comparison in turn consisted of summing all atom-atom interactions that were unique to each 
strain, and likewise comparing these sums. 
 
 Once these sums were executed, the comparison of the data had to have some threshold 
for what would be considered significant and what could be disregarded as deviations arising 
from experimental artifacts (these artifacts coming from the conditions employed in the 
crystallography experiments).  Normal artifacts due to experimental conditions that can vary on 
the atomic scale when crystallographic procedures are being executed is typically around 5-7%.  
Thus, the threshold for consideration was decided to be a minimum of approximately 10% 
difference between comparable criteria of both wild-type and mutant strains. 
 
5.0 SYSTEMS ANALYZED: TRANSTHYRETIN 
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 The first system considered in the analysis was the protein transthyretin.  Transthyretin in 
its physiological state is a tetramer made up of two sub-units where each subunit is in turn a 
homo-dimer.  The molecular weight of each monomer is 15.89 kDa for a total molecular weight 
of 63.56 kDa for the biologically active tetramer (“TTR(human),” 2014).  For this study, the 
homo-dimer was selected according to the availability, non-cysteine residue mutation and 
minimization of variability criteria discussed earlier.  Below is an image for the wild-type and 
mutant strains studied, accession numbers 3D7P and 3DJT respectively, 
 
 
 
Fig. 7: Dimer of transthyretin wild-type (7a) and mutant (7b).  Accession 
numbers 3D7P and 3DJT respectively. 
 
Figures A10 and A11 show the biologically active transthyretin tetramer as well as the above 
dimer from a different angle. 
 
Transthyretin is a carrier protein of two species: the thyroid hormone thyroxin and the 
lipocalin retinol binding protein which is itself bound to retinol (a form of vitamin A).  It is from 
the transport of these two molecules that transthyretin derives its name: transports thyroxin and 
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retinol (Palinathan, Mohamedmohaideen, Snee, Kelly, & Sacchettini, 2008).  The liver secretes 
transthyretin into the blood and the choroid plexus transports it into the cerebrospinal fluid.  
Thyroxin is a tyrosine-based hormone that acts on almost every cell in the body and ultimately 
plays a role in regulating the basal metabolic rate, long bone growth, neural maturation and even 
protein synthesis (Palinathan et al., 2008).  It is produced in the thyroid gland and requires iodine 
for its synthesis (Palinathan et al., 2008).  Incidentally, an iodine deficiency results in under-
production of this hormone which in turn results in enlarged thyroid glands, the condition of 
which is known as simple goiters.  One of the biological significances of transthyretin therefore 
lies in its ability to distribute thyroxin throughout the body so that the aforementioned biological 
processes of metabolism and cellular growth rate may not be impaired (Palinathan et al., 2008).  
The second chemical species transported by transthyretin, retinol, is responsible for a variety of 
functions such as maintaining vision, skin health, teeth re-mineralization, and bone growth 
(Palinathan et al., 2008).  The exact avenue by which retinol affects these diverse systems 
depends on what form retinol (an alcohol) is converted to.  As an aldehyde (retinal) it affects 
vision, as a carboxylic acid (retinoic acid) it affects skin health, teeth re-mineralization and bone 
growth (Palinathan et al., 2008). 
 
 Of important consequence to this study is the location of the active site for this and all the 
proteins that follow.  In total, transthyretin carries one thyroxin molecule, and two retinol 
molecules via the retinol binding protein.  For transthyretin, the studies by Monaco showed the 
active sites for the biologically active tetramer to be located on the outside of the complete 
tetrameric complex for the retinol binding protein, and within the cavity of the tetramer for 
thyroxin.  The following image shows these active sites, 
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Fig. 8: Retinol binding protein binding sites (red) and the thyroxin active site (green).  The 
retinol binding proteins are on the right and left of the transthyretin complex with retinol bound 
and shown as a space filling model.  The thyroxin binding site is shown empty.   
 
 When this protein is defective due to specific residue mutations, a serious condition 
known as Familial Amyloid Polyneuropathy (FAP) can occur (also known commonly as Corino 
de Andrade’s Disease, named after the Portuguese neurologist who first described it).  FAP is an 
autosomal dominant neurodegenerative disease characterized by pain, parathesia (pins-and-
needles sensations), muscular weakness and autonomic dysfunction (Cendron, Trovato, Seno, & 
et al., 2009).  As the scientific name of this disease suggests, FAP is an amyloidogenic disorder, 
(like Alzheimer’s and Parkinson’s diseases) wherein amyloid plaque builds up in the brain and 
results in a general loss of motor function (Cendron et al., 2009).  In FAP, amyloid plaques of the 
mutated protein accumulate in the peripheral nervous system causing a progressive sensory and 
  
36 
 
motor polyneuropathy (Cendron et al., 2009).  Polyneuropathies are damage to multiple nerves in 
roughly the same area on both sides of the body that lead to weakness, numbness, pins-and-
needles sensations (parathesia) and burning pain.  The heart and kidneys are affected in the 
terminal state of this disease (Ando & Jono, 2008).  The mutant strain of the transthyretin protein 
analyzed for this study was a missense mutation resulting in the replacement of Valine by 
Methionine at the 30th position (V30M) which was not located near any of the active sites (see 
Figure A10).  This is the mutation that is most commonly found in FAP cases (accession number 
3DJT) (Cendron et al., 2009).  Wild type transthyretin has a half-life of roughly two days in the 
body (Ando & Jono, 2008).  However no information could be gathered for the mutant version of 
the protein which would have provided useful insight relating the persistent amyloid deposits to 
the time they reside in the body.  OpenContac© was thus performed to analyze the inter-protein 
chain interactions for this system using Chain A of 3DJT mapped against Chain B of 3DJT.  Only 
these inter-protein interactions were analyzed, not the binding of the ligands of thyroxin or the 
retinol binding protein. 
 
 The so-called “Fine Parsing” results for the transthyretin mapping indicated that the 
mutant strain exhibited greater interaction from the Lennard-Jones criterion than the wild-type 
(Table 1).  From the total Coulombic interaction and the average distance criteria however, the 
differences between the two strains were not significant.  Note that “UL TOT” and “UCOUL 
TOT” are the sum of all Lennard-Jones and Coulombic atom pair interactions respectively from 
the Fine Parsing output. 
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Table 1: Fine Parsing Results for Transthyretin 
 WT MUT % 
UL TOT: -5.41E+01 -6.36E+01 15% 
UCOUL TOT: -2.38E+02 -2.46E+02 4% 
DISTANCE (AVG): 6.07E-01 5.82E-01 4% 
 
Statistically significant values are hi-lighted: red for potentials and blue for distances.  Thus 
overall, the two strains for this system seem to show little structural variance between them as far 
as their fine parsing inter-chain interactions were concerned.  Visually, this can be seen by 
comparing the fine parsing images (chains have been hi-lighted and labeled), 
 
        
Fig. 9: transthyretin wild-type (9a) and mutant (9b) fine parsing 
Wild-type residue range: 33-122 (A chain), 41-122 (B chain) 
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Mutant residue range: 39-122 (A chain), 39-122 (B chain) 
 
By considering the shift in Lennard-Jones interactions when going from the wild-type strain to 
the mutant strain, one can see that the mutation permits a novel situation wherein the non-
charged, non-polar residues are now interacting stronger in the mutant strain.  Non-charged and 
non-polar residues are usually associated with the interior region, or endo-domains, of a protein 
and are hydrophobic in nature so the conclusion from the overall analysis of the protein is that its 
interior has stronger hydrophobic interactions in the mutated form.  The schematic representation 
was used for fine parsing visualization, as it permits visualization of the most basic alpha carbon 
backbone which is very often lost with ribbon representation.  This paradigm will be used 
throughout this study. 
 
From a structural perspective, the coarse parsing also seemed to show overall retention of 
structure (Fig. 10). 
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Fig. 10: Transthyretin wild-type (10a) and mutant (10b) 
Wild-type residue range: 12-124 (A chain), 11-124 (B chain) 
Mutant residue range: 11-124 (A chain), 11-123 (B chain) 
 
 In order to further quantify changes in protein-protein interaction (PPI) behavior, 
common and un-common atom-atom interactions between the two strains were identified from 
OpenContact© Fine Parsing spreadsheets.  The common interactions were atom-atom pairs 
found in both wild-type and mutant strains whereas the un-common interactions represent those 
atom-atom pairs that were unique to each strain.  For this analysis, virtually every residue present 
in the whole fine parsing output had a constituent atom participate in common interactions (i.e. 
almost all residues are common residues).  The results for the common atom-atom interactions 
are shown in the Table 2. 
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Table 2: Common Results for Transthyretin 
 WT MUT % 
UL TOT: -3.68E+01 -3.59E+01 2% 
UCOUL TOT: -2.12E+02 -2.24E+02 5% 
DISTANCE (AVG): 5.94E-01 6.03E-01 1% 
COMMON ATOM-
ATOM PAIRS: 543 
 
 
For these interaction pairs, one can see that there was little deviation between the wild-type and 
mutant strains.  Intuitively, this makes sense as the atom-atom interaction pairs considered are 
identical in their participants between the wild-type and mutant with very little overall structural 
changes.  The analysis of the un-common interactions thus considered the remaining atom-atom 
pairs that were unique to each individual strain.  The results for this analysis are shown in Table 
3. 
 
Table 3: Un-common Results for Transthyretin 
 WT MUT % 
UL TOT: -1.72E+01 -2.77E+01 38% 
UCOUL TOT: -2.64E+01 -2.13E+01 19% 
DISTANCE (AVG): 6.35E-01 5.46E-01 14% 
UN-COMMON ATOM-
ATOM PAIRS: 258 307  
 
By identifying only the un-common interaction partners, a clear shift was seen going from 
Coulombic to Lennard-Jones when going from the wild-type to the mutant.  Additionally, the 
average inter-atomic distance decreased slightly as visually evident by overlaying Fig. 9a over 
Fig. 9b (not shown). It is interesting to note that despite these findings, the biology of the disease 
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state still permits transport of the two ligands (thyroxin and the retinol binding protein) (Cendron 
et al., 2009).  This is consistent with the lack of overall structural changes.  How the subtle 
change or shift in PPIs affects plaque formation is not known, but these PPI changes have been 
clearly detected here. 
 
5.1 SYSTEMS ANALYZED: SOD1 
 
 The next system that was analyzed was the enzyme SOD1.  The biologically active form 
of this enzyme is a homo-dimer with each monomer having a molecular weight of 15.94 kDa for 
a total molecular weight of 31.88 kDa for the whole protein (“SOD1 (human),” 2014).  Below is 
an image of the wild type and mutant strains that were used for this study (accession numbers 
4FF9 and 3GZQ respectively), 
 
 
Fig. 11: SOD1 dimer enzyme wild-type (11a) and mutant (11b).  Accession numbers 4FF9 and 
3GZQ respectively 
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 Superoxide dismutase 1, or SOD1, is an enzyme that is responsible for destroying 
superoxide radicals in the human body (Auclaire, Brodkin, D’Aquino, Petsko, Ringe & Agar, 
2013).  It belongs to a general family of enzymes known as superoxide dismutases that catalyze 
the dismutation of superoxide (O2-, a free radical) into diatomic oxygen and hydrogen peroxide 
thus making the enzyme an extremely important anti-oxidant (Auclaire et al., 2013).  The 
presence of superoxide in biological systems, specifically in humans, comes from the by-
products of mitochondrial respiration as well as from the immune system which specifically 
manufactures superoxide for use in oxygen-dependent killing mechanisms of foreign invading 
pathogens (Auclaire et al., 2013).  Being a free radical, superoxide is extremely toxic due to its 
high reactivity and can readily react with (and therefore alter) DNA.  The neutralization of 
superoxide is accomplished by the presence of metal ions in an accessible region of the protein 
(its active site, though more on this later) that consequently makes SOD1 and the other SOD 
proteins metalloproteins (Auclaire et al., 2013).  The three families are distinguished from one 
another according to the specific metal/metals present in the active site, which in turn dictates the 
location of activity (i.e. intracellular or extracellular) or the specific types of organisms serviced 
by the dismutase (Galaleldeen & Strange, 2009).  The subject of study for this project was the 
human superoxide dismutase known as SOD1 which is found in the cytoplasm of cells and 
contains copper and zinc as its active site metal ions, both of which are in the +2 oxidation state 
(Ramirez, Mejiba Gomez, & Mason, 2005).  The other two classes of SOD, SOD2 (which uses 
iron or manganese) and SOD3 (which uses nickel) are also found in humans in the mitochondria 
and extracellular fluids respectively (Selverstone Valentine, Doucette, & Zittin Potter, 2005).  
Prokaryotes will either use SOD2 or SOD3 for their superoxide neutralization protocols 
(Selverstone Valentine et al., 2005). 
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 Each individual monomer in SOD1 is built upon a β barrel motif with one copper and one 
zinc binding site.  Two large loops called the electrostatic and zinc loops encase the metal-
binding region which serves as the active site (although the heart of enzymatic activity revolves 
around the copper ion).  Thus the whole biologically active SOD1 enzyme has a total of two 
active sites, one on each monomer.  Below is the entire enzyme with the metal ions in the active 
site hi-lighted as reported by Selverstone Valentine et al., 
 
 
Fig. 12: SOD1 enzyme (wild-type) with loop regions and active site 
 
The overall enzymatic activity of SOD1 is described in the following chemical reaction equation 
as given by Selverstone Valentine et al.,    
 
(11) 2𝑂2
− + 2𝐻+ → 𝑂2 + 𝐻2𝑂2 
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where two hydronium ions (technically shown here as free protons) from the aqueous in vivo 
environment provide the necessary hydrogens to evolve hydrogen peroxide.  Considering the 
detailed chronological mechanism by which the cupric ion participates involves a two-step 
reaction process.  The first step is shown next, 
 
(12) 𝑂2
− + 𝐶𝑢2+𝑍𝑛𝑆𝑂𝐷 → 𝑂2 + 𝐶𝑢
+𝑍𝑛𝑆𝑂𝐷 
 
Here, one molecule of superoxide first reduces the cupric ion to the cuprous oxidation state (+1) 
to form diatomic oxygen.  The second reaction that yields the final hydrogen peroxide product is 
shown next, 
 
(13) 𝑂2
− + 2𝐻+ + 𝐶𝑢+𝑍𝑛𝑆𝑂𝐷 → 𝐻2𝑂2 + 𝐶𝑢
2+𝑍𝑛𝑆𝑂𝐷 
 
Thus the copper ion is returned to the cupric oxidation state thereby regenerating the enzyme for 
further activity. 
 
 Should a mutation occur, a disease known as amyotrophic lateral sclerosis or ALS 
(known as Lou Gehrig’s disease in the United States) can develop.  ALS is a neurodegenerative 
disease characterized by rapidly progressing weakness due to muscle atrophy, muscle spasticity, 
difficulty speaking, swallowing and breathing (Galaleldeen & Strange, 2009).  Although the 
disease can be inherited, this mode of acquisition only applies to about 5%-10% of cases (thus 
termed familial ALS) with the majority of incidents occurring spontaneously (Galaleldeen & 
Strange, 2009).  These symptoms are brought about by the gradual degeneration of the upper and 
lower motor neurons and although all voluntary movement is ultimately lost, bladder and bowel 
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functions as well as the muscles responsible for eye movement are typically spared until the final 
stages of the disease (Galaleldeen & Strange, 2009).  Interestingly, cognitive function is 
generally spared for most ALS patients, although some 5% of sufferers may develop 
frontotemporal dementia (Galaleldeen & Strange).  Survival time with this disease is around 39 
months from the onset of symptoms and death is ultimately caused by respiratory failure.  A 
well-known case of ALS is that of cosmologist Stephen Hawking who first started displaying 
symptoms during his years at Cambridge University as a doctoral student.  He has since lived 
with this disease for more than 50 years, however his case is exceptional.  The exact mechanism 
by which patients experience a gradual loss of neuronal function is as of yet still unknown, but 
aggregates of large fibrils of proteinaceous inclusions rich in mutant SOD1 are characteristic of 
tissue samples from ALS patients (Selverstone Valentine et al., 2005).  As has been proposed for 
ALS and other neurodegenerative diseases, the fibrils themselves may not be the toxic species as 
they are formed relatively late in the disease, but instead may be a final accumulation of the 
insoluble protein form as the body becomes incapable of handling such a large buildup.  This 
scenario might therefore lead one to believe that the half-life of the mutant strain is longer than 
that of the wild-type since fibrils of mutated protein are found in the aggregates.  Interestingly 
enough, this is not the case.  According to Selverstone Valentine et al., wild-type human SOD1 
has a half-life of 30 hours.  This is dramatically different from the mutant’s half-life (specifically 
the mutant that was studied) which is 7.5 hours.  The mutant strain utilized in this study was the 
A4V mutation, accession number 3GZQ. 
 
 The overall fine parsing analysis for SOD1 yielded results that were by and far too close 
between the wild-type and mutant strains to be considered favoring either.  Below is the table 
summarizing these results, 
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Table 4: Fine Parsing Results for SOD1 
 WT MUT % 
UL TOT: -3.99E+01 -4.07E+01 2% 
UCOUL TOT: -2.34E+02 -2.11E+02 10% 
DISTANCE (AVG): 6.55E-01 6.43E-01 2% 
 
 
Thus the data implies a striking similarity in binding interactions between both wild-type and 
mutant amongst all of the atom-atom interactions responsible for keeping the two sub-units 
together.  The pdb molecular representation for this fine parsing data is shown below, 
 
                                   
Fig. 13: SOD1 wild-type (13a) and mutant (13b) fine parsing 
Wild-type residue range: 3-153 (A chain), 1-153 (B chain) 
Mutant residue range: 1-153 (A chain), 3-153 (B chain) 
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Positions that underwent mutations are circled in Figures 15 and 16 as this will be the paradigm 
for all the images that are to follow, should there be a mutation present in the fine or coarse 
parsing output images.  One item of note to point out is that the original pdb input data file for 
the wild-type and mutant had the A and B chain nomenclature reversed.  This was of no 
consequence however for OpenContact© as the results yielded are not dependent on chain name. 
 
An interesting aspect of this case was that the residue position (the 4th position) that was 
mutated also participated in inter-chain binding as seen in Figures 15 and 16 (also recall Figure 
A11 which shows this residue position near the inter-chain region).  The specific differences 
between the interactions for the mutated position alone is shown in the table below, 
 
Table 5: SOD1 Mutant Position Comparison (4) 
 WT MUT % 
UL TOT: -7.53E-02 -5.21E-02 30% 
UCOUL TOT: -6.12E+00 -3.56E+00 42% 
DISTANCE (AVG): 7.62E-01 7.79E-01 2.00% 
 
Although the mutated residue position was present in the fine parsing studies for both strains, it 
is crucial to point out that not all of the same atom-atom binding pairs participated in binding.  
As it turned out, the wild-type had fourteen of its constituent binding pairs participate whereas 
the mutant only had ten.  Nonetheless, the wild-type’s binding pairs exhibited considerably 
stronger interactions as seen in Table 5.  Interestingly enough, despite superior binding from the 
wild-type, the average distance for both strains were almost identical. 
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 With respect to the structural changes, the mutant strain exhibited some considerable 
change from the wild-type and even showed the development of secondary structure in the form 
of an anti-parallel beta sheet.  These results are shown below, 
 
           
Fig. 14: SOD1 wild type (14a) and mutant (14b) coarse parsing 
Wild-type: 1-153 (A chain), 1-153 (B chain) 
Mutant: 1-153 (A chain), 2-153 (B chain) 
 
As can be seen, there is a significant change in structure in the mutant, particularly a noticeable 
introduction of beta sheet formation in the mutant as well as a re-orientation of sorts of the 
mirror image symmetry of the two mutant chains.  Where the wild-type has inverted mirror 
image symmetry (with each mutant position on opposite ends), the mutant is a very good mirror 
image of the two constituent chains.  More striking is how, as a result of this, the mutated 
position is now very much in symmetry in the mutant strain.  As in the fine parsing results, the 
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mutated residue shows up in both strains and is noticeably closer to the interior of the binding 
region in the mutant compared to the wild-type. 
 
 When considering the atom-atom interactions common to both the wild-type and mutant 
strains, a similar trend of virtually equal interactions across all three criteria is observed.  The 
following table summarizes these results, 
 
Table 6: Common Results for SOD1 
 WT MUT % 
UL TOT: -3.29E+01 -3.26E+01 1% 
UCOUL TOT: -2.00E+02 -1.99E+02 1% 
DISTANCE (AVG): 6.44E-01 6.42E-01 1% 
COMMON 
ATOM-ATOM 
PAIRS: 606 
 
As would be expected, there was practically no change of interaction type when going from the 
wild-type to the mutant strain.  As was observed for transthyretin, these common interactions 
pertained to virtually every residue from the fine parsing output. 
 
 Upon examination of the un-common interactions however, one can see that there begin 
to be signs of bias in favor of the wild-type strain or the mutant strain depending on the 
interaction criterion considered.  These results are summarized below, 
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Table 7: Un-common Results for SOD1 
 WT MUT % 
UL TOT: -6.91E+00 -8.10E+00 15% 
UCOUL TOT: -3.42E+01 -1.19E+01 65% 
DISTANCE (AVG): 7.00E-01 6.47E-01 8% 
UN-COMMON 
ATOM-ATOM PAIRS 148 108  
 
The results indicate that the mutant strain contains greater Lennard-Jones interactions, again 
strongly associated with non-polar residues, and that the wild-type presents an even greater 
proportion of electrostatic activity associated with polar residues. 
 
5.2 SYSTEMS ANALYZED: P53 
 
 The next system analyzed was p53, a protein highly involved in DNA repair and 
programmed cell death (apoptosis) that is strongly linked with incidences of cancer.  The 
biologically active form of P53 protein is that of a tetramer complex composed of four identical 
subunit chains.  Each chain has a mass of 43.7 kDa for a total mass of 174.8 kDa (“p53 
(human),” 2014).  Below is an image of wild-type p53 as it would be found executing its DNA 
reparative function as reported by Malecka, Ho, & Marmorstein, 2009, 
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Fig. 15: p53 tetramer complexed to DNA 
 
Although the above image is of the whole protein, it must be noted that crystallizing the entire 
protein is difficult due to the inherent flexibility of p53 that is part of its biological activity and 
function (more on this later) (Mora & Carbajo, 2008).  Thus the structure pdb file available for 
study was only of the tetramer’s binding domains.  The wild type strain employed for this study 
was of the accession number 2J0Z (Mora & Carbajo, 2008). 
 
 p53 is an important protein involved in repairing DNA damage and is thus extremely 
important in cancer cell systems (Goodsell, 2014).  Over 70% of all cancers exhibit some form of 
p53 mutations regardless of whether or not the mutations are acquired post-nattily or inherited 
(Gao et al., 2013).  In general, mutations that lead to cancer abide by either one of two 
mechanisms: a mutation that results in uncontrolled growth/multiplication of cells or mutations 
that block the normal defenses responsible for protecting against unnatural growth (Goodsell, 
2014).  Consequently, cancerous cells will exhibit mutations that affect either one (or possibly 
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even both) of these regulatory processes.  In the case of p53 the latter of the two mechanisms 
(unnatural growth protection) is regulated.  P53 is normally found in low levels, however, should 
DNA damage be detected, the levels of this protein would rise and initiate the production of 
proteins that halt cell division until the damage is repaired (Mora & Carbajo, 2008).  If the 
damage is too severe, however, p53 initiates the process of programmed cell death, or apoptosis, 
which ultimately directs the cell to commit suicide thus permanently removing it from the in-
vivo system (Mora & Carbajo, 2008).  When p53 executes its function, it binds to regulatory 
sites in the genome that in turn trigger the production of the aforementioned proteins such as 
WAF1 and G1-S/CDK (Mora & Carbajo, 2008).  In the case of WAF1 and G1-S/CDK, these two 
proteins complex together which results in the affected cell being unable to proceed with the next 
stage of cell division (Mora & Carbajo, 2008).  As the name G1-S/CDK implies, cell growth is 
usually halted at the G1/S phase by the complex that this protein participates in (Mora & 
Carbajo, 2008).  Due to the enormous benefit provided by p53, it is commonly given the nick-
name of tumor suppressor protein and guardian of the genome.  In all, the role p53 plays in 
neutralizing rogue cells is tantamount to the role of helper T cells in the immune system: both 
identify harmful pathogens (the immune system “foreign” and p53 “domestic”) and both invoke 
entities to do the actual neutralization of the target species. 
 
 As stated earlier, p53 binds to target regions/section of DNA that direct the transcription 
and ultimate translation of proteins such as WAF1 and G1-S/CDK.  Physically, this is 
accomplished by the p53 tetramer opening up from its normally closed binding domain and 
binding to the appropriate location on the gene (Mora & Carbajo, 2008).  It is important to point 
out however, that the structure to follow in Figure 20 does not bind to DNA.  Figure 16 shows 
the structure responsible for p53 chains binding to and amongst themselves for both the wild-
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type and mutant strains.  Malecka et al. reported the precise DNA binding residues (NOT the 
tetramer binding region) as being the 99th residue to the 289th.  The residues in Figure 16 (the 
binding region studied in this work) span from 326th to the 356th residues.  Thus below is an 
image of the wild-type and mutant binding domains of the protein for inter-chain, intra-protein 
stability which was also incidentally the structure used for this study (the chains are also 
labeled).  The accession number for the wild-type is 2J0Z and for the mutant it is 2J10. 
 
 
Fig. 16: p53 binding domain, wild-type (16a) and mutant (16b).  Accession numbers: 2J0Z and 
2J10 respectively. 
 
As can be seen, the tetramerization binding for this protein is a system of four alpha helices.  
Each helix corresponds to and is attached to one of the monomers that make up the rest of each 
monomer structure.  As briefly mentioned earlier, the protein is flexible and it is in the binding 
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domain that the flexibility is extremely important as this is the region wherein p53 binds to 
DNA.  This is unfortunately a problem for crystallographers as flexible proteins do not tend to 
form orderly crystals, and if they do crystallize, the results are often of a low resolution (Malecka 
et al., 2009).  Structural determination has thus been mostly elucidated by piece-wise studies on 
the protein, one of which is the binding domain featured in this study. 
 
 Mutations in p53 have a negative impact in the protein’s ability to carry out its function, 
particularly, its immediate ability to effectively bind to DNA.  The outcome of this impaired 
reparatory ability is ultimately cancer.  The human body is constantly being bombarded with 
materials such as chemicals, ionizing radiation, that all have the potential to interact with DNA 
and damage it (recall superoxide from mitochondrial respiration specially handled by SOD1).  A 
defective p53 will therefore not be able to invoke the proteins such as WAF1 and G1-S/CDK that 
halt an affected cell thus allowing the growth of a tumor (Mora & Carbajo, 2008).  In executing 
its function it is noteworthy to mention that the p53 DNA binding domains interact primarily 
with the major grooves of the DNA molecule (see Figure 19).  The mutant strain that was 
ultimately used sported two mutations at the 329th (T329F) and 331st (Q331K) positions not in 
the DNA binding domain and was of the accession number 2J10 (Mora & Carbajo, 2008).   
 
 One of the unique scenarios presented by this particular case was its multiplicity of 
chains (more than two) that required analysis.  This presented an opportunity to study the binding 
interactions present in the different combinations of chains to see what, if any trends could be 
found.  Thus the first module for p53 analysis focuses on the A-X chain family or combinations 
(i.e. A-B, A-C and A-D).  The other combinations will be considered later in their own separate 
module reviews.  For the overall Fine Parsing PPI analysis, the results are shown below, 
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Table 8: Fine Parsing Results for p53, A-B 
 WT MUT % 
UL TOT: -5.35E+01 -4.25E+01 21% 
UCOUL TOT: -3.04E+02 -2.60E+02 14% 
DISTANCE (AVG): 5.89E-01 6.08E-01 3% 
 
 
Table 9: Fine Parsing Results for p53, A-C 
 WT MUT % 
UL TOT: -1.56E+00 -1.10E+00 30% 
UCOUL TOT: -2.66E+01 -3.59E+01 26% 
DISTANCE (AVG): 8.04E-01 8.03E-01 0.1% 
 
 
Table 10: Fine Parsing Results for p53, A-D 
 WT MUT % 
UL TOT: -5.31E+00 -5.40E+00 2% 
UCOUL TOT: -6.87E+01 -7.81E+01 12% 
DISTANCE (AVG): 6.97E-01 7.11E-01 2% 
 
 
As can be seen, the overall Fine Parsing analysis yielded results that were relatively intuitive 
given the structure of the binding domain.  The A-B interactions (Table 8) yielded the greatest 
total interaction quantities and smallest average separation distances among all the other 
interaction pairs (A-C, A-D).  The difference was one order of magnitude greater for the A-B 
interactions compared against both A-C and A-D potentials.  Average distances between wild-
type and mutant strains, however, remained in the same order of magnitude for all three A-X 
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interactions.  One can see by visual inspection of Fig. 20 that in the overall structure, the greatest 
inter-chain overlap indeed occurs between the A-B chains and, thus, the data corroborates that 
these two chains certainly have the strongest interaction potentials.  “Second place” in total 
interaction potential went to the A-D chain interaction system with the next largest potentials and 
smallest separation distances.  Needless to say, A-C by far had the weakest interactions.  When 
tracking the shifts in potentials across the A-X chain family, we observe that there is an overall 
decrease in in both Lennard-Jones and Coulombic potentials when going from the wild-type to 
the mutant for the A-B chain interaction system.  For the A-C pair, we see that there was a shift 
from Lennard-Jones to Coulombic likewise when going from the wild-type to the mutant and for 
the A-D chain interaction system there was an increase in Coulombic interactions. 
 
 Considering the associated Fine Parsing structure for these three interaction scenarios, 
one can see that the mutated positions show up most predominantly in the A-B chain interactions 
(Fig. 17).  We can thus see that the mutated residues play an important role in binding for the 
mutant strain and may account for the behavior noted the preceding discussion.  The fine parsing 
images for these results follow, 
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Fig. 17: p53 wild-type (17a) and mutant (17b) Fine Parsing, A-B 
Wild-type: 326-352 (A chain), 326-352 (B chain) 
Mutant: 326-356 (A chain), 326-352 (B chain) 
 
     
Fig. 18: p53 wild-type (18a) and mutant (18b) Fine Parsing, A-C 
Wild-type: 336-344 (A chain), 336-344 (C chain) 
Mutant: 335-343 (A chain), 335-343 (C chain) 
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Fig. 19: p53 wild-type (19a) and mutant (19b) Fine Parsing, A-D 
Wild-type: 343-354 (A chain), 343-354 (D chain) 
Mutant: 339-355 (A chain), 342-354 (D chain) 
 
From analyzing the above images, one can see that the A-B interaction system clearly had more 
atoms participate in binding (so much that some degree of structure was even identified by DS 
Viewer Pro©), thus accounting for the stronger overall interactions observed for the A-B system.  
This stands in stark contrast to the fine parsing images for the A-C and A-D interactions that 
clearly have fewer atoms participating in their binding and do not have any recognizable 
associated structure.  Additionally, one can see that atoms from both mutated residue positions 
(the 329th and 331st residues) contributed to A-B interactions for both the wild-type and the 
mutant, but only one select atom from the mutation at the 331st residue played any role in the A-
C and A-D binding and only for the mutant strain. 
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Upon examination of the coarse parsing results, one can see that structurally, there is little 
difference between the wild-type and the mutant.  Although, as will be seen, there are some slight 
differences with actual atomic orientations and angles, these differences manifest themselves 
closer to the binding intra-protein, inter-chain domain of the tetramer and do not appear to be 
overwhelmingly impactful on the overall morphology of the protein.  Below are images taken 
from these results, 
 
     
Fig. 20: p53 wild-type (20a) and mutant (20b) coarse parsing, A-B 
Wild-type: 326-352 (A chain), 326-352 (B chain) 
Mutant: 326-356 (A chain), 326-352 (B chain) 
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Fig. 21: P53 wild-type (21a) and mutant (21b) coarse parsing, A-C 
Wild-type: 336-348 (A chain), 334-351 (C chain) 
Mutant: 330-351 (A chain), 335-351 (C chain) 
 
 
Fig. 22: P53 wild-type (22a) and mutant (22b) coarse parsing, A-D 
Wild-type: 337-355 (A chain), 336-355 (D chain) 
Mutant: 336-356 (A chain), 337-355 (D chain) 
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 When analyzing the common residue component of this system (common atom-atom pair 
interactions for the A chain and X chain interactions), there are slight shifts in the total common 
interaction potential values (Tables 14-16) with a slight weakening in A-B mutant interactions 
over the wild-type strain.  Chain interactions A-C and A-D experience a shift in Coulombic and 
Lennard-Jones interactions respectively when going from the wild-type to the mutant. 
 
Table 14: Common Results for p53 (A-B) 
 WT MUT % 
UL TOT: -2.12E+01 -1.83E+01 14% 
UCOUL TOT: -2.14E+02 -1.78E+02 17% 
DISTANCE (AVG): 6.07E-01 6.37E-01 5% 
COMMON ATOM-
ATOM PAIRS: 428 
 
 
Table 15: Common Results for p53 (A-C) 
 WT MUT % 
UL TOT: -6.80E-01 -7.02E-01 3% 
UCOUL TOT: -2.24E+01 -2.55E+01 12% 
DISTANCE (AVG): 8.27E-01 7.78E-01 6% 
COMMON ATOM-
ATOM PAIRS: 42 
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Table 16: Common Results for p53 (A-D) 
 WT MUT % 
UL TOT: -1.67E+00 -2.13E+00 22% 
UCOUL TOT: -5.43E+01 -4.90E+01 10% 
DISTANCE (AVG): 7.19E-01 7.22E-01 0.4% 
COMMON ATOM-
ATOM PAIRS: 105 
 
 However, for the uncommon interaction partners, the result is a dramatic shift from 
Lennard-Jones to Coulombic interactions which on the whole is consistent with residue side 
chain behavior given that the mutant has a Phenylalanine (non-polar) replacing a Threonine 
(polar) and a Lysine (charged) replacing a Glutamine (polar).  Thus in the end, the mutations 
provide charged species that were lacking in the wild-type. 
 
Table 17: Un-common Results for p53 (A-B) 
 
 
 
 
 
Table 18: Un-common Results for p53 (A-C) 
 WT MUT % 
UL TOT: -8.76E-01 -4.03E-01 54% 
UCOUL TOT: -4.20E+00 
-
1.04E+01 60% 
DISTANCE (AVG): 7.42E-01 8.41E-01 12% 
UN-COMMON 
ATOM-ATOM PAIRS: 16 27  
 
 WT MUT % 
UL TOT: -3.22E+01 -2.42E+01 25% 
UCOUL TOT: -9.01E+01 -8.15E+01 10% 
DISTANCE (AVG): 5.74E-01 5.76E-01 0.4% 
UN-COMMON 
ATOM-ATOM PAIRS: 490 396  
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Table 19: Un-common Results for p53 (A-D) 
 WT MUT % 
UL TOT: -3.64E+00 -3.27E+00 10% 
UCOUL TOT: -1.44E+01 -2.91E+01 51% 
DISTANCE (AVG): 6.54E-01 7.00E-01 7% 
UN-COMMON 
ATOM-ATOM PAIRS: 54 93  
 
 
Given the participation of the mutated residues, it is interesting to note how the 
interaction quantities compare from the wild-type to the mutant.  Since the mutated position was 
present in both the wild-type and mutant strains in the fine parsing of the A-B interaction system, 
the following analysis was carried out.  This was not the case with A-C and A-D however which 
had a mutant residue position only show up in the mutant strain.  The following three tables 
present these findings, 
 
Table 11: p53 Mutant Position Comparison (329 & 331) 
 WT MUT % 
UL TOT: -2.12E+01 -5.83E+00 73% 
UCOUL TOT: -1.44E+02 -5.05E+01 65% 
DISTANCE (AVG): 5.77E-01 6.22E-01 7% 
 
As can be seen, interactions are greater in the wild-type for both Lennard-Jones and Coulombic 
interactions.  As observed with the overall analysis previously discussed, the Coulombic 
interactions are greater within the wild-type and this observation serves as a testament to the 
nature of the forces that dominate in the endo-domain binding region of p53. 
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 The above analysis results were for the combined effects of both positions that exhibited 
mutations.  Considering now just the 329th position, one can see yet again the bias towards the 
wild-type strain in having stronger interactions.   
 
Table 12: p53 Mutant Position Comparison (329) 
 WT MUT % 
UL TOT: -1.80E+01 -2.37E+00 87% 
UCOUL TOT: -1.06E+02 -1.47E+01 86% 
DISTANCE 
(AVG): 5.47E-01 5.73E-1 5% 
 
 
Interestingly enough, the average inter-atomic distances between wild-type and mutant 
practically did not change.  Even though the wild-type strain clearly had better interactions, once 
again, we see the dominance of electrostatic forces as being considerably greater than Lennard-
Jones forces (electrostatic Coulombic interaction potentials were greater by an order of 
magnitude). 
 
Looking at the 331st position now, one can see an interesting turn of events for the 
ranking of inter-atomic binding with the scenario now showing no preference for either strain, 
 
Table 13: p53 Mutant Position Comparison (331) 
 WT MUT % 
UL TOT: -3.24E+00 -3.46E+00 6% 
UCOUL TOT: -3.85E+01 -3.58E+01 7% 
DISTANCE 
(AVG): 6.71E-01 6.45E-01 4% 
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Although there are practically no changes when going from one strain to another, one can 
definitely see that the coulombic electrostatic forces predominate in both strains nonetheless.  
This is interesting to note due to the fact that glutamine (present in the wild-type) is typically 
treated and behaves as an uncharged amino acid in contrast to lysine (present in the mutant) 
which is treated as a charged amino acid due to its side group.  Nevertheless, the two amino acids 
behave very similarly to each other as evidenced by the magnitude of their Lennard-Jones and 
Coulombic interaction values. 
 
 Now that the A-X family of interactions has been described and discussed, we proceed to 
the next module for consideration of the chain combination: B-X.  Since the original 
combinations for a quaternary chain system apply to only two members for the B-X family (B-C 
and B-D), there are consequently only two combinations to look at now as opposed to the three 
that there were for the A-X family (A-B, A-C and A-D).   As before, the analysis for this family 
will begin with the overall calculation results. 
 
Table 20: Fine Parsing Results for p53 (B-C) 
 WT MUT % 
UL TOT: -3.74E+00 -7.15E+00 48% 
UCOUL TOT: -5.46E+01 -8.33E+01 34% 
DISTANCE (AVG): 7.24E-01 6.91E-01 5% 
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Table 21: Fine Parsing Results for p53 (B-D) 
 WT MUT % 
UL TOT: -2.48E+00 -1.25E+00 50% 
UCOUL TOT: -2.70E+01 -1.18E+01 56% 
DISTANCE (AVG): 7.68E-01 7.81E-01 2% 
 
 
As far as raw magnitudes are concerned, the B-C interaction system is definitely showing greater 
attractions.  Furthermore within B-C, one can see that the mutant version of the protein exhibits 
greater interactions for both potentials.  This is in contrast to the “second place” B-D system that 
favors wild-type interactions (again, for both potentials).  Interestingly enough, although the B-D 
system is weaker overall, it nonetheless shows the most dramatic changes in potential 
magnitudes going from the wild-type to the mutant when compared against B-C’s percent 
differences.  As has been typical thus far (with the exception of the uncommon results for the A-
C interactions) the distances have remained relatively constant and have not changed much 
between wild-type and mutant strains.   
 
 Turning one’s attention to the fine parsing results, we can see that overall the distribution 
of atoms in space responsible for binding is relatively the same among wild-type and mutant.  
Overall residue participation was low, but slightly greater for the B-C system.  Below are the 
image results for this portion of the study, 
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Fig. 23: P53 wild-type (23a) and mutant (23b) fine parsing, B-C 
Wild-type: 343-354 (B chain), 343-354 (C chain) 
Mutant: 342-354 (B chain), 343-354 (C chain) 
 
           
Fig. 24: P53 wild-type (24a) and mutant (24b) fine parsing, B-D       
Wild-type: 712-916 (B chain), 336-343 (D chain) 
Mutant: 336-344 (B chain), 336-344 (D chain) 
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Unlike in the A-X family, the mutated position (329 and 331) did not participate in binding in the 
B-X family of interactions. 
 
 Like its predecessors in the A-X module, the coarse parsing for all B-X interactions 
revealed that overall, the structure was generally well-preserved when going from the wild-type 
to the mutant.  Especially observed with the B-C interactions, some individual residue’s 
constituent moieties and atoms did acquire novel orientations/positions in the mutant strain, but 
apart from these slight details, there was little to suggest a major change in the structure 
concerned with the quatramer’s intra-protein binding site.  The images below detail these 
observations, 
 
   
Fig. 25: P53 wild-type (25a) and mutant (25b) coarse parsing, B-C 
Wild-type: 337-356 (B chain), 337-355 (C chain) 
Mutant: 337-356 (B chain), 337-355 (C chain) 
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Fig. 26: P53 wild-type (26a) and mutant (26b), B-D 
Wild-type: 336-351 (B chain), 335-351 (D chain) 
Mutant: 336-351 (B chain), 336-351 (D chain) 
 
Of a particularly interesting note was the slight reduction in alpha helical structure observed in 
the B-D system for both mutants’ chains.  Such a visual reduction further substantiates the fine 
parsing evidence that the wild-type stain is more stable and exhibits stronger intra-protein 
interactions.  An item of note is the symmetry that the A-D chain interactions have with the B-C 
chain interactions.  Such a similarity is taken from the perspective of the coarse parsing results 
for these two chains and is really not too surprising given the symmetry of the native protein. 
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Table 22: Common Results for p53 (B-C) 
 WT MUT % 
UL TOT: -2.35E+00 -2.68E+00 12% 
UCOUL TOT: -4.59E+01 -5.42E+01 15% 
DISTANCE (AVG): 7.27E-01 7.16E-01 2% 
COMMON 
ATOM-ATOM 
PAIRS: 115 
 
 
Table 23: Common Results for p53 (B-D) 
 WT MUT % 
UL TOT: -1.25E+00 -9.54E-01 24% 
UCOUL TOT: -8.08E+00 -8.78E+00 8% 
DISTANCE 
(AVG): 7.94E-01 7.85E-01 1% 
COMMON 
ATOM-ATOM 
PAIRS:  23  
 
 
The B-C system additionally showed that the mutant version of the protein was 
particularly stronger than the wild-type across both interaction criteria (Lennard-Jones and 
Coulombic).  Thus the behavior of the common atom pairs were equal in their nature to the 
behavior of all the atom pairs from the overall analysis.  As seen the foregoing analyses prior to 
the B-X family’s, virtually every residue that participated in binding for the overall analysis was 
exactly represented in the analysis for common atom-atom interactions.  There was some 
deviation from this observation for the wild-type B-D case which had a total of eleven residues 
present in binding interactions in the A chain alone.  Out of these eleven residues, only five had 
constituent atoms that participated in common interactions with the mutant strain.  The B-D 
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mutant strain by contrast had every single residue contribute to the common atom-atom 
interactions which again was typical of every system studied thus far.  As before, distance data 
proved to conform more to typical values (between 7 to 9 dimensionless distance units). 
 
 Focusing on the uncommon results now, one can still see the B-C system reigning as the 
chain interaction pair with the most influential binding compared against the B-D system.  These 
results are shown below, 
 
Table 24: Uncommon Results for p53 (B-C) 
 WT MUT % 
UL TOT: -1.39E+00 -4.47E+00 69% 
UCOUL TOT: -8.63E+00 -2.91E+01 70% 
DISTANCE (AVG): 7.15E-01 6.61E-01 8% 
UN-COMMON 
ATOM-ATOM PAIRS: 46 98  
 
 
Table 25: Uncommon Results for p53 (B-D) 
 WT MUT % 
UL TOT: -1.23E+00 -2.95E-01 76% 
UCOUL TOT: -1.89E+01 
-
3.05E+00 84% 
DISTANCE (AVG): 7.55E-01 7.74E-01 2% 
UN-COMMON 
ATOM-ATOM PAIRS: 49 10  
 
 
The B-C system clearly shows superior interactions in both potential types within the mutant 
strain pertaining to a shift in interactions to both Lennard-Jones and Coulombic, just as it did in 
the common analysis thus indicating a stronger, better bound mutant.  The B-D system by 
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contrast showed superior interactions in the wild-type strain with some considerable losses of 
both these Lennard-Jones and Coulombic potentials in the mutant thus yielding weaker B-D 
binding in the mutant..  The un-common analysis for the B-D interactions however proved to be 
slightly different in that the Coulombic potential for the wild-type was now considerably greater 
than its wild-type counterpart in the mutant strain (in contrast to the common analysis which 
showed the Coulombic interactions to be relatively equal).  Thus the end result for the B-X chain 
interaction family is a small net overall change in the kinds of potentials present in those two 
chain interaction systems. 
 
 The final module for p53 that is now thus addressed is the C-D interaction system.  As 
before, data for the overall analysis of the entire fine parsing output data file is shown below for 
this system, 
 
Table 26: Fine Parsing Results for p53 (C-D) 
 WT MUT % 
UL TOT: -5.92E+01 -5.31E+01 10% 
UCOUL TOT: -2.79E+02 -2.81E+02 1% 
DISTANCE (AVG): 5.82E-01 5.91E-01 2% 
 
 
As can be seen, the interaction parameters are relatively equal and thus do not change much 
when going from the wild-type to the mutant.  Of interesting note however is the rather short 
distance (compared to the other analyses) that exists within both wild-type and mutant strains.  
So far only the analysis for the mutated position at position 329 (see Table 12) has yielded 
smaller values for inter-chain distances (5.47E-1 for the wild-type and 5.73E-1 for the mutant). 
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 The fine parsing images indicated the presence of both mutated positions as participants 
in inter-chain binding between C and D for both the wild-type and mutant.  This is reminiscent of 
the mutated positions likewise showing up in the fine parsing for the A-B system.  The images 
showing these results are below, 
 
   
Fig. 27: p53 wild-type (27a) and mutant (27b) fine parsing, C-D 
Wild-type: 326-352 (C chain), 326-352 (D chain) 
Mutant: 326-352 (C chain), 326-356 (D chain) 
 
As has been seen throughout this study, virtually every single residue had atoms that participated 
in fine parsing interactions.  The only exceptions to this were the two mutated positions, 329 and 
331, that are shown in the images above. 
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 Continuing with the coarse parsing, we can see that like all of the preceding structures, 
the structure has been well-preserved and unchanged when going from the wild-type to the 
mutant strain.  As pointed out before, some atoms and moieties managed to get slightly moved in 
orientation when introducing the mutations.  As was observed with the A-X family, both 
mutations were present in the coarse parsing structures as well.  The images below showcase 
these results, 
 
 
Fig. 28: p53 wild-type (28a) and mutant (28b) coarse parsing, C-D 
Wild-type: 326-356 (C chain), 326-355 (D chain) 
Mutant: 326-356 (C chain), 326-356 (D chain) 
 
 Turning attention to the common interactions, we can see that there were virtually no 
differences between the wild-type and mutant interaction pairs when going from one strain to 
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another.  To put it another way, wild-type and mutant C-D interaction chain behaviors were the 
same. 
 
Table 30: Common Results for p53 (C-D) 
 WT MUT % 
UL TOT: -2.76E+01 -2.84E+01 3% 
UCOUL TOT: -1.79E+02 -1.83E+02 2% 
DISTANCE (AVG): 6.09E-01 6.02E-01 1% 
COMMON ATOM-
ATOM PAIRS: 471 
 
 
 When considering the un-common interactions, we see a relatively modest difference 
between the wild-type and the mutant.  In all, the only significant observable difference was the 
wild-type losing Lennard-Jones interactions to the mutant by 22%, whereas the values for 
Coulombic interactions and inter-atomic distances remained very close to each other across each 
strain.  The results are shown in the table below, 
 
Table 30: Un-common Results for p53 (C-D) 
 WT MUT % 
UL TOT: -3.16E+01 -2.47E+01 22% 
UCOUL TOT: -1.00E+02 -9.82E+01 2% 
DISTANCE (AVG): 5.57E-01 5.79E-01 4% 
UN-COMMON 
ATOM-ATOM PAIRS: 483 435  
 
 
Thus the wild-type remains as the better bound system for the C-D interaction pairs with 
Lennard-Jones interactions slightly going down in the mutated state. 
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 Since the mutated positions showed up like in the C-D chain interactions (see Fig. 27), 
what follows now is an analysis that compares how the two residues behaved in terms of their 
constituent atoms/ potentials and distances.  Below are the results of this inquiry, 
 
Table 27: Mutant Position Comparison (329 & 331) 
 WT MUT % 
UL TOT: -6.76E+00 -6.77E+00 0.1% 
UCOUL TOT: -6.55E+01 -4.78E+01 27% 
DISTANCE (AVG): 6.33E-01 5.80E-01 8% 
 
Remarkably enough, the results from all of the constituent atoms for both mutated positions 
behaved almost identically.  Only the wild-type exhibited a considerable decrease in its 
Coulombic interactions (thus the wild-type was better bound) with the two values differing by 
27%.  As before, the distances remained very close to each other. 
 
 Focusing now on just the 329th residue position, we begin to see some deviation in 
potential behavior.  These results are in the table below, 
 
Table 28: Mutant Position Comparison (329) 
 WT MUT % 
UL TOT: -3.22E+00 -4.50E+00 28% 
UCOUL TOT: -5.37E+01 -1.63E+01 70% 
DISTANCE (AVG): 5.95E-01 4.99E-01 16% 
 
 
Although the wild-type showed considerably stronger Coulombic interactions, the mutant strain 
ultimately displayed the most varied changes in the form of Lennard-Jones interactions 
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increasing, and the inter-atomic distances decreasing, all of which are hallmarks of improved and 
stronger interactions.  The sharp decrease observed in the Coulombic interactions going from the 
wild-type to the mutant is consistent with what is known from the identity of the missense 
mutation covered here: the wild-type 329th residue is threonine which is a polar amino acid and it 
is replaced by a phenylalanine which is a non-polar amino acid.  It thus makes sense that the 
polar influence should decrease given its replacement with something non-polar.  In terms of 
distance, this was one of the few instances where the distance parameter changed noticeably, and 
for this case, it changed in favor of the mutant (the mutant is now closer among its chains). 
 
 Lastly, we now turn to the 331st mutated residue position.  When considering only this 
position, the results indicated that the wild-type had superior interactions in both potentials and 
no changes to inter-atomic distances were observed.  These results are shown below, 
 
Table 29: Mutant Position Comparison (331) 
 WT MUT % 
UL TOT: -3.54E+00 -2.27E+00 36% 
UCOUL TOT: -3.87E+01 -3.15E+01 19% 
DISTANCE (AVG): 6.57E-01 6.57E-01 0% 
 
 
 Thus in all, one can see a wide variation of results for the different combinations of 
chains, even when they are within the same protein.  In some cases the common interactions for 
the different strains are truly carbon copies of each, which is intuitive and makes sense, but in 
other scenarios, they are different enough to warrant further investigation using additional tools 
such as dynamic studies.  For p53, it can thus be concluded that mutations have a competing (i.e. 
Lennard-Jones increasing but Coulombic decreasing at the same time) effect although weakening 
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the structure somewhat.  The changes observed are not dramatic enough to prevent the tetramer 
from binding amongst its constituent chains, but they are sufficient to alter its binding ability to 
DNA. 
 
5.3 SYSTEMS ANALYZED: HRAS 
 
 The next system analyzed was for another protein with strong associations with cancer 
(akin to p53): HRAS.  The HRAS protein is made of a 21.45 kDa single chain (“Hras (human),” 
2014) unlike the other protein systems analyzed thus far (which had two or more chains) so in 
this respect, its analysis approach was unique and required a novel consideration that was 
unnecessary before for the other systems (more on this later).  Below is an image of HRAS wild-
type that was employed for this study (accession number 4EFL) (Muraoka, Shima, Araki, & et 
al., 2012), 
 
 
Fig. 29: HRAS wild-type (29a) and mutant (29b) 
 
 HRAS is a protein responsible for the regulation of cell division and cell growth.  The 
regulation itself is triggered in response to growth factor stimulation (Muraoka et al., 2012).  
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Growth factors are a class of chemicals, namely, cytokines, hormones and proteins that positively 
affect cell growth and development (Muraoka et al., 2012).  It is typically from an extracellular 
environment that HRAS interacts with these compounds and thus HRAS is usually associated 
with cell membranes due to the presence of an isoprenyl group on its C-terminus (Muraoka et al., 
2012).  Once the appropriate cell signals have been received, stimulation of signal transduction 
events by means of recruiting additional proteins such as c-Raf and PI 3-kinase within the 
cytoplasm direct the cell to continue growing and divide (a transduction event is the process by 
which proteins and secondary messengers relay signals from the outside of the cell to the cell 
nucleus) (Muraoka et al., 2012).  Thus HRAS responds in an agonistic manner in response to the 
growth factors and is an early player in this particular cell signaling chain of command given its 
position at the front end of the process.  The specific mechanism by which HRAS accomplishes 
its function in relaying the appropriate message in response to growth factor (or the absence 
thereof) is the enzymatic cleavage of GTP (guanosine triphosphate) to GDP (guanosine 
diphosphate) (Muraoka et al., 2012).  When HRAS is bound to GDP, the protein is said to be off 
and it will not recruit downstream proteins to execute cell division.  When HRAS is bound to 
GTP however, the protein is said to be on and instructions to carry out cell division and growth 
will be conveyed to the nucleus (Muraoka et al., 2012).  Thus the process of turning HRAS “on” 
involves the enzymatically assisted hydrolysis of GTP to GDP specifically removing a phosphate 
group from the 5’ carbon of the ribose sugar, and turning the protein “off” involves the re-
phosphorylation of GDP to GTP accomplished with the help of pyruvate kinase, a 
phosphorylating enzyme (Muraoka et al., 2012). 
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 With respect to the binding site of this protein, there are technically two, but only one is 
specifically involved in the pathology associated with aberrant HRAS forms.  The image below 
details these binding sites as reported by Miyakawa, Morikawa, Takasu, & et al., 2013, 
 
 
Fig. 30: HRAS binding sites, GDP complex (off) 
 
With regards to the GTP/GDP dependency of the on/off status of HRAS, the loop in Figure 45 
labeled as Switch I houses the GTP/GDP molecule mentioned earlier (Miyakawa et al., 2013).  
The second loop, called Switch II, in turn houses a molecule of water for the de-phosphorylation 
of GTP via hydrolysis (Miyakawa et al., 2013).  When a mutation manifests itself in HRAS, the 
danger lies in how that mutation will affect the Switch I loop (Franken, Scheidig, Krengel, & et 
al., 1993).  If the mutation should result in the “on” position (GTP bound state) remaining as a 
permanent state by preventing the normal enzymatic hydrolysis activity, then cancer may very 
well result due to the perpetual signal for the cell to grow and multiply (Franken et al., 1993).  
Thus wherein the danger with mutated p53 was in growth no longer being halted, the danger 
with mutated HRAS is that growth is now permitted excessively.  Should HRAS be negatively 
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affected by a congenital mutation, then the result may be what is known as Costello syndrome 
(named after the New Zealand pediatrician who first reported this disorder to the Australian 
Paediatric Journal) (Franken et al., 1993).  This disease is characterized by delayed development, 
mental retardation, cancerous (and non-cancerous) tumors, distinctive facial features, unusually 
flexible joints and heart abnormalities such as tachycardia (an extremely fast heartbeat) (Franken 
et al., 1993).  Although the tumors are explained via the function of HRAS, researchers are as of 
yet still unsure as to how the other disease characteristics (especially mental retardation) 
manifest from aberrant HRAS production.  The most common mutation resulting in Costello 
syndrome replaces the amino acid glycine at the twelfth position with serine (Franken et al., 
1993).  The mutation that was employed for this study replaced glycine at this same position but 
with aspartic acid instead (mutant accession number: 1AGP) (Franken et al., 1993).  Both strains, 
wild-type and mutant, were in the “on,” GTP bound state.  The final location chosen was the 57th 
residue such that the first “sub” chain of HRAS would contain Switch I and the second “sub” 
chain would contain Switch II.  Thus the first “sub” chain contained residues 1-57 and the second 
“sub” chain contained the residues 58-166 which marked the end of the HRAS chain.  The image 
below shows this demarcation with the 57th residue hi-lighted in dark blue, 
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Fig. 31: HRAS splitting location 
 
 Table 30 shows the overall analysis for the Fine Parsing of the HRAS system as 
described above.  We can see that the mutant strain had better binding interactions.  Although 
both Lennard-Jones and Coulombic forces increased, the attractive Coulombic interactions 
increased the most when going from the wild-type to the mutant.   
 
Table 30: Fine Parsing Results for HRAS 
 WT MUT % 
UL TOT: -8.02E+01 -9.07E+01 12% 
UCOUL TOT: -3.81E+02 -4.98E+02 23% 
DISTANCE (AVG): 6.09E-01 6.06E-01 0.5% 
 
 
 The first thing worth mentioning when considering the Fine Parsing images (Fig. 32) for 
the overall analysis of this system is that the specific arrangement of atoms in space changes 
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somewhat noticeably when going from the wild-type to the mutant strain.  The other detail 
worthy of note is that the mutated residue position appears in the Fine Parsing Results for both 
strains and is therefore a direct participant in the interactions between Switch I and Switch II 
domains. 
 
   
Fig. 32: HRAS wild-type (32a) and mutant (32b) Fine Parsing, sub-chains: 1-57 & 58-166 
Wild-type: 1-57 (sub-chain 1-57), 58-165 (sub-chain 58-166) 
Mutant: 1-57 (sub-chain 1-57), 58-165 (sub-chain 58-166) 
 
It is interesting to note that despite the seemingly different arrangement of the atoms in the 
mutant compared against the wild-type, the data discussed in the foregoing paragraph 
nonetheless indicate that average inter-chain atomic distances remained virtually identical.   
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 As can be seen from the coarse parsing analysis (Fig. 33), the Switch I loop is missing 
from the wild-type structure but is present in the mutant.  Thus OpenContact’s © results indicate 
that there indeed is a difference involving structure between the wild-type and the mutant to the 
conclusion that the Switch I loop in the mutant is more proximal to the Switch II loop than in the 
wild-type strain.  This is consistent with the known pathological characteristics of mutated 
HRAS where the GTP in Switch I is negatively affected by somehow being shielded from de-
phosphorylation hydrolysis (which is what should happen) thus leaving GTP permanently 
unchanged in the Switch I loop.  This may lead to the observed rampant cellular growth and 
division associated with the mutant strain. 
 
 
Fig. 33: HRAS wild-type (33a) and mutant (33b) coarse parsing, sub-chains: 1-57 & 58-166 
Wild-type: 1-57 (sub-chain 1-57), 58-166 (sub-chain 58-166) 
Mutant: 1-57 (sub-chain 1-57), 58-166 (sub-chain 58-166) 
 
 When considering the common interaction partners (Table 32), we can see that there is 
very little variation between the wild-type and mutant strains again.   
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Table 32: Common Results for HRAS 
 WT MUT % 
UL TOT: -5.98E+01 -5.59E+01 7% 
UCOUL TOT: -3.46E+02 -3.50E+02 1% 
DISTANCE (AVG): 6.08E-01 6.11E-01 1% 
COMMON ATOM-
ATOM PAIRS: 937 
 
 When considering the un-common interactions (Table 33), we see a shift in interactions 
going in favor of the mutant, with a rather substantial increase, specifically in the Coulombic 
attractive interactions. 
 
Table 33: Un-common Results for HRAS 
 WT MUT % 
UL TOT: -2.04E+01 -3.48E+01 41% 
UCOUL TOT: -3.49E+01 -1.48E+02 76% 
DISTANCE (AVG): 6.17E-01 5.99E-01 3% 
UN-COMMON ATOM-
ATOM PAIRS: 278 574  
 
 
Thus when comparing the uncommon atom-atom interaction pairs to the common interaction 
pairs, it can be seen that the changes effected to the mutant (of most importance to the Switch I 
loop) entirely come from the uncommon interactions.  Furthermore, these uncommon 
interactions are considerably stronger for the mutant thus indicating that whatever hindrance is 
imposed upon GTP in the Switch I loop stems from an inherently in-flexible loop that does not 
permit the catalytic cleavage that this enzyme is supposed to execute. 
 
  
86 
 
An interesting result that had not been observed thus far was that although out of all the 
wild-type’s residues, each participated in common binding (except the position that was to be 
mutated of course), the mutant itself had five extra residues that did not participate at all in 
common interactions with the wild-type strain.  These extra residues in the mutant that were 
foreign to the wild-type’s binding were residues 27-30.  The wild-type strain thus exhibited 48 
residue interactions and the mutant 53. 
 
 Upon close inspection and comparison of the mutated residue in the wild-type and 
mutant, one can see that they are both remarkably similar.  The only real difference is a modest 
gain in Lennard-Jones interactions by the mutant which is curious in that the aspartic acid that 
defines the mutant is charged, more so than the glycine in the wild-type.  Thus one would expect 
an increase in Coulombic interactions, but reality defied this expectation.  The results are 
presented in the table below, 
 
Table 31: Mutant Position Comparison (12) 
 WT MUT % 
UL TOT: -1.22E+00 -1.67E+00 27% 
UCOUL TOT: -8.80E+00 -8.73E+00 1% 
DISTANCE (AVG): 2.21E+01 2.02E+01 9% 
 
As has become a hallmark of these systems, the distance remained unchanged is the closest by 
far among the specific cases wherein a mutated residue position participated in binding. 
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5.4 SYSTEMS ANALYZED: DHFR 
 
The next system protein studied was the 21.45 kDa, enzyme dihydrofolate reductase, or 
DHFR (“DHFR (human),” 2014).  Like HRAS, this protein was also a one chain monomeric 
system.  The wild-type structure that was employed for this study was of the accession number 
1DRF (Oefner, D’Arcy, & Winkler, 1988). 
 
 DHFR is an enzyme produced in the liver that is responsible for the reduction of 
dihydrofolic acid to tetrahydrofolic acid using the cofactor nicotinamide adenine dinucleotide 
phosphate (NADPH) as an electron donor (see image below),   
 
 
Fig. 34: NADPH with DHFR-relevant moieties 
 
Tetrahydrofolic acid is an important precursor in the in-vivo bio-synthesis of purines and 
pyrimidines which in turn serve as the building blocks of DNA and RNA (Oefner, D’Arcy, & 
Winkler, 1988).  DHFR thus serves as a catalyst for the important building blocks of genetic 
material and it is therefore found in every dividing cell, eukaryotic or otherwise.  The mechanism 
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of enzymatic activity was stated by Oefner et al. as being the transfer of a hydride from NADPH 
to dihydrofolate with an accompanying protonation to produce tetrahydrofolate.  As will be 
explored in more detail shortly, an important location on this protein known as the Met20 loop 
helps to stabilize the nicotinamide ring of the NADPH (see Figure 52) to promote the transfer of 
the hydride from the NADPH to the dihydrofolate (Ulrich, Akutsu, Doreleijers, & et al., 2014) . 
 
 DHFR is generally divided into two major sub-domains: the adenosine-binding sub-
domain and the loop sub-domain (Cario , Smith, Blom, & et al., 2011).  The adenosine-binding 
subdomain is the larger of the two and it binds the adenosine moiety of NADPH (see Figure 52) 
(Cario et al., 2011).  The loop sub-domain contains three loops, the Met-20 loop (mentioned in 
the foregoing paragraph), the F-G loop and the G-H loop (Ulrich et al., 2014).  In between these 
two sub-domains lies a long groove structured by a large beta sheet and an alpha helix which is 
the active site where folate and NADPH bind together (Ulrich et al., 2014).  The overall location 
of these structures and the active site is shown in the following image as reported by Ulrich et al., 
 
 
 
Fig. 35: DHFR wild-type with ligand binding domains (35a) and mutant (35b).   
Cleavage site: VAL112.  Wild-type accession number: 1DRF, mutant accession number: 3EIG. 
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As will be expounded upon shortly, the binding behavior of this protein that can affect human 
health is the binding of NADPH to DHFR (Oefner et al., 1988).   
 
 Should mutations occur near or on the loop sub-domain, DHFR may have problems 
adequately binding to NADPH, specifically, the nicotinamide moiety (Volpato, Yachnin, 
Blanchet, & et al., 2009).  As reported by Ulrich et al., the Met 20 loop regulates NADPH 
binding by being flexible and allowing the cofactor access to its binding site.  Thus mutations 
that affect the loop sub-domain, specifically the Met 20 loop, may have negative consequences in 
DHFR even binding to its NADPH ligand and carrying out its function.  If such a congenital 
mutation were to manifest itself, a disorder known as megaoloblastic anemia can occur (Volpato 
et al., 2009).  In this disorder, a deficiency of tetrahydrofolate (the product of DHFR and 
dihydrofolate) results in inadequate DNA synthesis for red blood cell production (Volpato et al., 
2009).  When DNA synthesis is impaired, the cell cycle cannot continue beyond the G2 growth 
stage to the M (mitosis) stage.  Thus a common hematological trademark of megaloblastic 
anemia are (as the name “megaloblastic” might imply) abnormally large and dysfunctional red 
blood cells in the bone marrow.  Like many other kinds of anemia, symptoms of this variety of 
the disease are fatigue, weakness, difficulty concentrating and general malaise (Volpato et al., 
2009).  For this study, a mutant strain was analyzed with two mutations: F31R and Q35E  These 
mutations were both located on the alpha helix superior to the loop sub-domain.  The mutant’s 
accession number was 3EIG (Volpato et al., 2009).  Since DHFR is a monomeric protein, it had 
to be cleaved in order to feed it to OpenContact©.  The location of thus breaking the pdb file was 
position 112 and it was so chosen so that the two sub-domain NADPH binding regions would be 
separate (see Figure 35). 
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 The results for the overall Fine Parsing analysis of this system showed that the mutant 
had gained Lennard-Jones interactions, although the gain was relatively modest.  The table below 
details these results, 
 
Table 32: Fine Parsing Results for DHFR 
 WT MUT % 
UL TOT: -1.31E+02 -1.53E+02 14% 
UCOUL TOT: -4.56E+02 -4.77E+02 4% 
DISTANCE (AVG): 5.87E-01 5.79E-01 1% 
 
 
 The pictorial fine parsing results for DHFR show that overall three-dimensional binding 
atom distribution remained relatively constant between the two strains.  Of note was that residues 
of the Met 20 loop were present in the fine parsing files for both strains indicating that it did play 
a direct, significant role in intra-protein interactions.  The Met 20 loop region is encircled in 
yellow in the Fig. 36. 
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Fig. 36: DHFR wild-type (36a) and mutant (36b) Fine Parsing, sub-chains: 1-112 & 113-186 
Wild-type: 2-112 (sub-chain 1-112), 113-184 (sub-chain 113-186) 
Mutant: 2-112 (sub-chain 1-112), 113-184 (sub-chain 113-186) 
 
Also 31st residue position that was ultimately mutated, played a role in the wild-type and mutant 
interactions.  It was also observed that every residue that participated in fine parsing interactions 
had constituent atom-atom pairs that were common to both strains. 
 
 When considering the coarse parsing structures, we can see that the mutant strain 
acquired more structure in that it now has an additional helix that did not play a role in the wild-
type.  Apart from this detail, the remainder of the structure was identical.  The images are below, 
MET20 LOOP REGION MET20 LOOP REGION 
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Fig. 37: DHFR wild-type (37a) and mutant (37b) coarse parsing, sub-chains: 1-112 & 113-186 
Wild-type: 1-112 (sub-chain 1-112), 113-186 (sub-chain 113-186) 
Mutant: 1-112 (sub-chain 1-112), 113-186 (sub-chain 113-186) 
 
Again, as in the fine parsing image results, the 31st residue showed up as a structural participant 
in both strains.  The 35th position also showed up here, though not in the fine parsing results. 
 
 The common results showed practically no variation between the wild-type and the 
mutant.   These results are in the table below, 
 
Table 36: DHFR Common Results 
 WT MUT % 
UL TOT: -1.02E+02 -1.06E+02 4% 
UCOUL TOT: -4.79E+02 -4.89E+02 2% 
DISTANCE (AVG): 5.97E-01 5.90E-01 1% 
COMMON ATOM-
ATOM PAIRS: 1427 
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 The results for the un-common interactions indicated a curious balance between Lennard-
Jones interactions and Coulombic repulsion.  Both strains have an attractive Lennard-Jones 
criterion and repulsive Coulombic interactions.  Of particular note was the dominant shift in 
Lennard-Jones interactions that the mutant strain exhibited compared to the wild-type (the wild-
type had a Lennard-Jones to Coulombic ratio of approximately 1.2 compared to the mutant 
which had a Lennard-Jones to Coulombic ratio of around 3.9). 
 
Table 37: DHFR Un-common Results 
 WT MUT % 
UL TOT: -2.84E+01 -4.62E+01 39% 
UCOUL TOT: 2.29E+01 1.20E+01 48% 
DISTANCE (AVG): 5.36E-01 5.44E-01 1% 
UN-COMMON ATOM-
ATOM PAIRS: 281 447  
 
 
The results for comparing the behavior of both the wild-type and mutant residue (position 
31) yielded results that indicated that the mutant strain of the protein had superior binding 
potentials compared to the wild-type.  The table below summarizes these results, 
 
 
 
Table 34: DHFR mutant position (31) 
 WT MUT % 
UL TOT: -9.35E-03 -2.60E-02 64% 
UCOUL TOT: -1.39E+00 -2.18E+00 36% 
DISTANCE (AVG): 8.97E-01 7.75E-01 14% 
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As was observed with the overall analysis, the mutant residue showed the steepest increase in 
Lennard-Jones potentials which seems counter-intuitive.  The expectation of the mutant’s 
charged arginine amino acid would be that it should have a greater increase in Coulombic 
interactions than the wild-type. 
 
5.5 SYSTEMS ANALYZED: HUNTINGTIN 
 
 The final protein analyzed in this study was the huntingtin protein (HTT).  It is a trimer 
protein (a three chain system) with each monomer having a molecular weight of 347.60 kDa for 
a total of 1042.8 kDa for the whole, biologically active protein (“Huntingtin (human),” 2014).  
As the name suggest, this protein is implicated in Huntington’s disease, a neurodegenerative 
disorder.  Due to the extreme difficulty in crystallizing this protein, the following structure below 
for the wild-type strain of what was studied is only of the structure of the N-terminal region 
(accession number 3IO4), 
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Fig. 38: HTT wild type N-terminus (38a) and mutant (38b) 
Wild type accession number: 3IO4 
Mutant accession number: 4FE8 
 
It is important to note that the pdb file corresponding to the above image was of the Huntingtin 
protein’s N-terminus stabilized by a maltose binding protein to help retain structural stability 
during crystallization (Kim, Chelliah, Kim, Otwinowski, & Bezprozvanny, 2009).  This maltose 
binding protein was manually omitted for the study however and only this segment of the 
huntingtin protein was subjected to analysis.  As with p53, this system involved considering the 
interactions from the different combinations of chain interaction partners (i.e. A-B, A-C, etc…). 
 
 Huntingtin is an elusive protein in that its exact role in vivo is not clearly understood 
(Kim et al., 2009).  Experiments with transgenic mice where the gene that encodes for huntingtin 
has been deleted (knockout) have proven lethal to the rodents (Kim et al., 2009).  This protein is 
highly expressed in neurons and testes of both humans and rodents and interestingly, it has no 
sequence homology with any other protein (Kim et al., 2009).  Huntingtin has also been shown 
to upregulate the expression of the nerve factor Brain Derived Neurotrophic Factor (BDNF) at 
the transcription level, but the exact mechanism of how this is accomplished is not known either 
(Kim et al., 2009).  From various experiments in electron microscopy and 
immunohistochemistry, it has been found that Huntingtin is primarily associated with the intra-
cellular machinery of vesicles and microtubules (Kim et al., 2009). 
 
 Although Huntingtin is known to interact with many proteins in the human body (most 
famously the Huntingtin Interacting Protein or HIP), due to its presently unknown mechanism of 
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function, there is really no active site to presently report of for this protein (although the protein 
itself is ubiquitously found in the cytoplasm of cells) (Kim et al., 2009).  Thus the perspective of 
this study will instead focus on a unique aspect of mutated Huntingtin’s pathology: a longer than 
normal polyglutamine segment (known as a polyglutamine expansion) that is associated with 
Huntingtin aggregates in infected systems (Kim, 2013).  Huntingtin’s disease occurs when the 
polyglutamine expansion exceeds 36 glutamines near the amino terminus although the cellular 
mechanisms that link this expansion to disease manifestation is still under investigation (Kim, 
2013).  The following image shows the location of the polyglutamine region in the mutant strain 
that was studied (accession number 4FE8) (Kim, 2013).  This mutant strain had thirty-six 
glutamine residues, 
 
 
Fig. 39: Huntingtin mutant (accession number: 4FE8) 
 
  
97 
 
The glutamine expansion region starts with the 388th residue (Kim, 2013).  It is important to note 
that not all thirty-six glutamines in the polyglutamine region were captured by the 
crystallographic experiment that yielded the above structure.  As one can envision from the C 
chain however (which presented the most complete polyglutamine region), the polyglutamine 
region would simply extend all three chains in the figure’s triangular configuration outward.  
How this extension would affect inter-chain binding (if it affects it at all) is the subject of this 
study.  With respect to pathology, most evidence is consistent with the hypothesis that the 
expanded protein acquires a “toxic gain of function (Kim, 2013).”  Apart from the aggregates, 
other toxic properties incumbent on expanded Huntingtin have been observed to be negative 
effects on gene transcription, induction of apoptosis, and disruption of key neuronal functions 
such as axonal transport, synaptic transmission, and Ca+2 signaling (Kim, 2013).  As stated by 
Kim et al., 2009, “many of the proposed mechanisms suggest that expanded Huntingtin is 
involved in pathological interactions with other signaling proteins in cells, leading to neuronal 
dysfunction and death.”  The mutant strain studied was a form of Huntingtin with thirty-six 
glutamines: pdb accession number: 4FE8. 
 
 The first combination that will be considered in the overall analysis is the A-X family of 
chains.  As can be seen from Tables 38 and 39, there were some substantial shifts in the nature of 
the potentials that dominated between the wild-type and the mutant.  In general, the most 
dramatic changes were observed to take place between the A-C chain interactions.   
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Table 38: Fine Parsing Results for Huntingtin (A-B) 
 WT MUT % 
UL TOT: -7.83E+00 -3.31E+00 58% 
UCOUL TOT: -1.32E+01 -1.24E+01 6% 
DISTANCE (AVG): 5.57E-01 6.42E-01 13% 
 
 
Table 39: Fine Parsing Results for Huntingtin (A-C) 
 WT MUT % 
UL TOT: -8.20E+00 -3.05E+00 63% 
UCOUL TOT: -8.86E+00 -1.11E+01 20% 
DISTANCE (AVG): 5.68E-01 6.45E-01 12% 
 
 
In the A-B interactions there was an overall reduction in the attractive forces in going from wild-
type to mutant whereas in A-C, there were compensating effects of decreases in Lennard-Jones 
attractions and increases in Coulombic attractions.   An interesting item of note is that the 
presence of a polyglutamine region in the mutant apparently creates more distance between the 
chains for both strains (the mutant average distance is longer in both).  In general though, the 
similarity between A-B and A-C is not too surprising given the near equilateral triangular 
geometry that Huntingtin’s N-terminus (see Figure 58). 
 
 Considering the pictorial representation for the fine parsing results (Fig. 40), we can see 
that the polyglutamine region participated in binding effects for the A-B wild-type interactions, 
but not for for the A-B mutant despite its expanded role in the mutant. 
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Fig. 40: Huntingtin wild-type (40a) and mutant (40b) Fine Parsing, A-B 
Wild-type: 373-413 (A chain), 371-391 (B chain) 
Mutant: 372-384 (A chain), 371-377 (B chain) 
 
 
Fig. 41: Huntingtin wild-type (41a) and mutant (41b) Fine Parsing, A-C 
Wild-type: 371-412 (A chain), 371-384 (C chain) 
Mutant: 371-377 (A chain), 372-384 (C chain) 
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No presence of the glutamine region was found in the any of the A-C interactions, wild-type or 
mutant (Fig. 41). 
 
 The coarse parsing results showed that the wild-type of both A-B and A-C chains had 
more secondary structure than the mutant which is consistent with the increased atom-atom 
separation distances (Figs. 42 and 43).  The A-B and A-C chain wild-types furthermore had the 
polyglutamine region participating in structure.  Only the A-C system’s mutant had the 
polyglutamine region however.  These results are presented in the images below, 
 
  
 
Fig. 42: Huntingtin wild-type (42a) and mutant (42b) coarse parsing, A-B 
Wild-type: 372-415 (A chain), 371-395 (B chain) 
Mutant: 372-388 (A chain), 371-381 (B chain) 
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Fig. 43: Huntingtin wild-type (43a) and mutant (43b) coarse parsing, A-C 
Wild-type: 371-413 (A chain), 371-391 (C chain) 
Mutant: 371-381 (A chain), 372-391 (C chain) 
 
 Looking at the common atom-atom interaction results from the Fine Parsing data (Tables 
40 and 41), we see, first of all, that the A-B interaction system was not truly affected in any 
meaningful way.  For the A-C chain system however, we see that the mutant results were 
significantly different from the wild-type even for the same of common atom-atom pair 
interactions. 
 
Table 40: Common Results for Huntingtin (A-B) 
 WT MUT % 
UL TOT: -8.20E-01 -7.77E-01 5% 
UCOUL TOT: -9.34E+00 -9.05E+00 3% 
DISTANCE (AVG): 6.94E-01 6.95E-01 0.2% 
COMMON ATOM-
ATOM PAIRS: 23 
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Table 41: Common Results for Huntingtin (A-C) 
 WT MUT % 
UL TOT: -6.77E-02 -1.43E-01 53% 
UCOUL TOT: -5.37E+00 -6.77E+00 21% 
DISTANCE (AVG): 8.22E-01 7.54E-01 8% 
COMMON ATOM-
ATOM PAIRS: 14 
 
 
Upon studying the un-common results for the A-X family, we first of all see that both 
inter-chain interaction systems (A-B and A-C) were indirectly affected by the polyglutamine 
expansion region when going from the wild-type to the mutant.  The un-common atom-atom 
pairs are not directly associated with the additional residues of the mutant (Fig. 41).  We 
additionally see that the A-B system’s mutant attractive interactions were diminished over the 
wild-type strain with a concomitant increase in inter-atomic distances.   
 
 Table 42: Un-common Results for Huntingtin (A-B) 
 WT MUT % 
UL TOT: -7.01E+00 -2.53E+00 64% 
UCOUL TOT: -3.90E+00 -3.34E+00 14% 
DISTANCE (AVG): 5.07E-01 6.03E-01 16% 
UN-COMMON 
ATOM-ATOM PAIRS: 62 31  
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Table 43: Un-common Results for Huntingtin (A-C) 
 WT MUT % 
UL TOT: -8.13E+00 -2.91E+00 64% 
UCOUL TOT: -3.49E+00 -4.38E+00 20% 
DISTANCE (AVG): 5.21E-01 6.06E-01 14% 
UN-COMMON ATOM-
ATOM PAIRS: 76 39  
 
 
The A-C pair was more varied in that its wild-type had better Lennard-Jones potentials and 
distance, but the mutant version had stronger Coulombic interactions. 
 
 Finally we turn our attention to the B-X family of interactions which for this case, only 
contained one member: B-C.  The overall results for B-C are as follows, 
 
Table 44: Fine Parsing Results for Huntingtin (B-C) 
 WT MUT % 
UL TOT: -6.85E-01 -3.08E+00 78% 
UCOUL TOT: -9.37E+00 -1.03E+01 9% 
DISTANCE (AVG): 7.86E-01 6.32E-01 20% 
 
 
As can be seen, the mutant version of the protein has considerably better attractive interactions 
than the wild-type, specifically with respect to the Lennard-Jones potential and distance.  Of 
interest was the dramatic increase (78%) of binding due to Lennard-Jones interactions for the 
mutant which was higher than any of the Lennard-Jones potential increases observed in the A-X 
family. 
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 Looking at the Fine Parsing image results, we can see that the mutant strain has greater 
numbers of atom-atom interaction partners compared to the wild-type.  In addition, these binding 
atoms are even more densely arranged for the mutant than for the wild-type which is (at least 
from a qualitative perspective) consistent with the data from Table 44. 
 
Fig. 44: Huntingtin wild-type (44a) and mutant (44b) Fine Parsing, B-C 
Wild-type: 372-383 (B chain), 371-374 (C chain) 
Mutant: 372-384 (B chain), 371-377 (C chain) 
 
 Coarse parsing image results show an overall retention of structure when going from the 
wild-type to the mutant.  Detailed inspection of the two structures, however, shows that the 
mutant strain has slightly developed more structure than the wild-type.  This development of 
structure is indicative of greater stability for the mutant which is hinted at in Table 44 by the 
increase in Lennard-Jones interactions and a decrease in average inter-atomic distance. 
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Fig. 45: Huntingtin wild-type (45a) and mutant (45b) coarse parsing, B-C 
Wild-type: 372-391 (B chain), 371-381 (C chain) 
Mutant: 372-391 (B chain), 371-381 (C chain) 
 
The results for the common atom-atom pair interactions likewise indicated that the 
mutant strain had somewhat stronger attractive interactions, although the distances changed 
negligibly (Table 45).   
 
Table 45: Common Results for Huntingtin (B-C) 
 WT MUT % 
UL TOT: -3.47E-01 -4.88E-01 29% 
UCOUL TOT: -7.38E+00 -8.69E+00 15% 
DISTANCE (AVG): 7.77E-01 7.36E-01 5% 
COMMON ATOM-
ATOM PAIRS: 21 
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With the un-common interactions, it was observed that the Lennard-Jones potential 
increased when going from the wild-type to the mutant quite dramatically (by 87%) and the 
Coulombic potential decreased, but not as sharply (only 21%). 
 
Table 46: Un-common Results for Huntingtin (B-C) 
 WT MUT % 
UL TOT: -3.37E-01 -2.60E+00 87% 
UCOUL TOT: -2.00E+00 -1.58E+00 21% 
DISTANCE (AVG): 8.04E-01 5.54E-01 31% 
UN-COMMON 
ATOM-ATOM PAIRS: 10 28  
 
 
The dramatic increase in the Lennard-Jones potential for the mutant, however, was also 
accompanied by a decrease in average inter-atomic distance. 
 
6.0 RESULTS AND DISCUSSION 
 
 This study proved very insightful in terms of the behavior that many seemingly un-
related protein systems exhibited.  As it turned out (and this occurred purely by coincidence), the 
six systems could be broken down into three main groups (where each group contained two 
protein systems), where each group was defined by a certain set of characteristics.  Those three 
groups were originally identified by whether or not the biological activity of the protein was 
affected by the mutation(s).  Other criteria were soon discovered to adhere to a trend marked by 
characteristics such as acquisition of additional secondary structure by the mutant and number of 
chains of the biologically active protein.  It is important to note that although these observations 
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may hint at a potential classification system for intra-protein behavior, the study of additional 
systems is necessary to determine if classification can indeed be obtained.  These observations 
are shown in Table 47. 
 
Table 47: Potential PPI Organization Scheme 
  
Biology  
affected? 
Mutant gains 
secondary 
structure? 
Strain favored 
by potential 
shift? 
Number of 
chains? 
Total 
number of 
ligands? 
CLASS1 TRANS No No Mutant 4 3 
  SOD1 No Yes Neither 2 2 
CLASS2 DHFR Yes Yes Mutant 1 2 
  HRAS Yes Yes Mutant 1 2 
CLASS3 P53 Yes No Wild Type 4 1 
 HUNT Unknown No Wild Type 3 Unknown 
 
 
These results were compiled from the overall Fine Parsing analyses of each system.  For ease of 
comparison, these specific Fine Parsing results are in the appendix, Figs. B1-B6.  Thus there may 
be a paradigm that unifies protein systems of diverse functions which may provide a rational 
means for studying these systems and developing therapeutics and treatments for them, but 
again, further studies on many more systems would be necessary before any such trends can be 
declared. 
 
7.0 FUTURE WORK 
 
 In light of the observations summarized in Table 47, it would be prudent and interesting 
to test further cases that fall into one of the three general classes outlined.  Do all one-chain 
protein systems whose mutants exhibit acquired secondary structure have the mutant strain 
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favored with higher Lennard-Jones and Coulombic values?  Will such systems always have their 
biological function impaired by the mutation(s)?  These are questions which can be undertaken 
as a direct “spin-off” from the results of the research reported in this work. 
 
 Additionally, one can extend further studies that make use of dynamic molecular 
simulations and models to further investigate why the observations reported in this work are so 
in the first place.  With that research question in mind, it is important to remember that although 
OpenContact© is a powerful tool to begin dissecting and investigating proteins, the results it 
renders are purely from a static paradigm that do not take protein dynamics into consideration.  
As has been reported for proteins such as p53, many systems’ biological activity rely on the 
ability to open up to accommodate ligands.  Unfortunately, one can miss out on a lot of these 
conformational changes when dynamic considerations are neglected. 
 
 Lastly, now that theoretical work has been conducted on the select systems discussed in 
this paper, perhaps the next level of inquiry could involve devising methods to detect these 
systems in vivo.  Perhaps a protocol that makes use of bio-mimetic peptides or aptamers can be 
developed to indicate if these aberrant proteins are present, and even to indicate the degree of 
aberrancy (a mutated p53 binds poorly to its ligand, this is not necessarily a guarantee of no 
binding whatsoever).  In short, novel, additional technologies can potentially be developed that 
may advantage of any substantiated trends observed in later studies. 
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APPENDIX A 
 
  Table A1 (pdb structure file anatomy): 
1 2 3 4 5 6 7 8 9 10 11 12 
ATOM 7 N PRO A 11 36.535 13.092 36.537 1.00 32.680 N 
ATOM 8 CA PRO A 11 35.653 12.829 35.409 1.00 31.150 C 
ATOM 9 C PRO A 11 36.326 12.719 34.040 1.00 29.600 C 
ATOM 10 O PRO A 11 35.659 12.367 33.077 1.00 28.290 O 
 
 
 
 
 
Fig. A1:  Information section of a typical pdb file 
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Fig. A2: Coordinate and atom data section (what DS Viewer Pro plots) 
 
 
 
Fig. A3: Flat ribbon transthyretin with  
overlaid atoms shown in wire-frame  
schematic 
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Fig. A4: Transthyretin in wire schema                           Fig. A5: Transthyretin in stick schema 
 
                         
Fig. A6: Transthyretin in line ribbon schema           Fig. A7: Transthyretin in schematic schema 
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Fig. A8: Tetramer of transthyretin                     Fig. A9: Dimer of transthyretin                                            
(biologically active tetramer) 
 
 
Fig. A10: Mutated residues hi-lighted in  
transthyretin 
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Fig. A11: Mutated residues hi-lighted in  
SOD1 
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APPENDIX B 
 
B1: 
p53 Symmettry: 
A-B                                                                        C-D 
                                                                                
 
A-C                                                                       B-D 
   
 
A-D                                                                       B-C 
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B2: 
Huntingtin Symmetry: 
A-B                                                                        A-C 
  
 
B-C 
 
 
B3: 
Transthyretin:                                                         
 
 
B4: 
SOD1: 
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B5: 
DHFR: 
 
 
B6: 
HRAS: 
 
 
